antigen.epitope	exposure.type	assay.type	assay.target.cells	assay.stimulator.cells	assay.immunogen.type	assay.immunogen	assay.type.1	assay.result	assay.measurement	assay.n	assay.n.resp	assay.freq.resp	tissue	cell.type	mhc	pmid	authors
QTVTSTPVQGR	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell	HLA-A*68:01	15694996	Corinna La Rosa; Zhongde Wang; Simon F Lacey; Susan F Markel; Madeva C Sharma; Joybelle Martinez; Maria M Lalimarmo; Don J Diamond
TTVYPPSSTAK	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro					qualitative binding	Positive					Blood	PBMC	HLA-A*03:01	15694996	Corinna La Rosa; Zhongde Wang; Simon F Lacey; Susan F Markel; Madeva C Sharma; Joybelle Martinez; Maria M Lalimarmo; Don J Diamond
KLEDLERDL	Occurrence of infectious disease						qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	15448372	Yi-Hsiang Huang; Mi-Hua Tao; Cheng-po Hu; Wan-Jr Syu; Jaw-Ching Wu
KLEDLERDL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KLEDLERDL	IFNg release	Positive					Blood	PBMC	HLA-A*02:01	15448372	Yi-Hsiang Huang; Mi-Hua Tao; Cheng-po Hu; Wan-Jr Syu; Jaw-Ching Wu
LITGRLQSL	Occurrence of infectious disease						IFNg release	Positive-High					Blood	PBMC	HLA-A2	15140958	Yue-Dan Wang; Wan-Yee Fion Sin; Guo-Bing Xu; Huang-Hao Yang; Tin-yau Wong; Xue-Wen Pang; Xiao-Yan He; Hua-Gang Zhang; Joice Na Lee Ng; Chak-Sum Samuel Cheng; Jing Yu; Li Meng; Rui-Feng Yang; Sik-To Lai; Zhi-Hong Guo; Yong Xie; Wei-Feng Chen; Huang-Hua Yang
ITKKVADLVGF	Administration in vivo	Restimulation in vitro	T cell CD8+				cytotoxicity	Positive					Blood	T cell	HLA-B*57:02	15104676	V Corbi&egrave;re; H Nicolay; V Russo; V Stroobant; V Brichard; T Boon; P van der Bruggen
ITKKVADLVGF	Administration in vivo						cytotoxicity	Positive					Blood	T cell CD8+	HLA-B*57:01	15104676	V Corbi&egrave;re; H Nicolay; V Russo; V Stroobant; V Brichard; T Boon; P van der Bruggen
ITKKVADLVGF	Administration in vivo	Restimulation in vitro	T cell CD8+				TNFa release	Positive					Blood	T cell CD8+	HLA-B*57:01	15104676	V Corbi&egrave;re; H Nicolay; V Russo; V Stroobant; V Brichard; T Boon; P van der Bruggen
AEWPTFNVGW	No immunization	Primary induction in vitro	T cell CD8+	B cell	Source Antigen	gag protein	IFNg release	Positive					Lymphoid	T cell	HLA-B*44:03	15496958	E Kondo; Y Akatsuka; A Nawa; K Kuzushima; K Tsujimura; M Tanimoto; Y Kodera; Y Morishima; K Kuzuya; T Takahashi
APIWPYEILY	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	Other	Structurally Related	Protein E6	IFNg release	Positive					Blood	T cell CD8+	HLA-B*35:01	15496958	E Kondo; Y Akatsuka; A Nawa; K Kuzushima; K Tsujimura; M Tanimoto; Y Kodera; Y Morishima; K Kuzuya; T Takahashi
LIYDSSLCDL	Occurrence of cancer						IFNg release	Positive		8			Blood	PBMC	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
LIYDSSLCDL	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	LIYDSSLCDL	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
YLLPRRGPRL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLLPRRGPRL	IFNg release	Positive		5	2	40	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
YLLPRRGPRL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLLPRRGPRL	cytotoxicity	Positive		5	2	40	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
DLMGYIPLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	DLMGYIPLV	IFNg release	Positive		5	4	80	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
DLMGYIPLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	DLMGYIPLV	cytotoxicity	Positive		5	1	20	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
LLALLSCLTV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLALLSCLTV	IFNg release	Positive		5	1	20	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
LLALLSCLTV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLALLSCLTV	cytotoxicity	Positive		5	1	20	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
KLVALGINAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KLVALGINAV	IFNg release	Positive		5	1	20	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
GLIEKNIEL	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	GLIEKNIEL	cytotoxicity	Positive						T cell CD8+	HLA-A2	15382068	Martina Berg; Eilon Barnea; Arie Admon; Nicholas Zavazava
GLIEKNIEL	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	GLIEKNIEL	cytotoxicity	Positive						T cell CD8+	HLA-A2	15382068	Martina Berg; Eilon Barnea; Arie Admon; Nicholas Zavazava
GLIEKNIEL	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	GLIEKNIEL	cytotoxicity	Positive						T cell CD8+	HLA-A2	15382068	Martina Berg; Eilon Barnea; Arie Admon; Nicholas Zavazava
GLIEKNIEL	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	GLIEKNIEL	IFNg release	Positive						T cell CD8+	HLA-A2	15382068	Martina Berg; Eilon Barnea; Arie Admon; Nicholas Zavazava
GLIEKNIEL	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	GLIEKNIEL	qualitative binding	Positive	0.74					T cell CD8+	HLA-A2	15382068	Martina Berg; Eilon Barnea; Arie Admon; Nicholas Zavazava
ALAHGVRAL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALAHGVRAL	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
NLPGCSFSI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	NLPGCSFSI	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
ILHTPGCV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ILHTPGCV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
SMVGNWAKV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SMVGNWAKV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
SLLAPGAKQNV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLLAPGAKQNV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
CINGVCWTV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	CINGVCWTV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
LLCPAGINAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLCPAGINAV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
TGAPVTYSTY	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	TGAPVTYSTY	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
SLMAFTAAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLMAFTAAV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
LLFNILGGWV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLFNILGGWV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
ILAGYGAGV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ILAGYGAGV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
ILDSFDPLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ILDSFDPLV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
RLIVFPDLGV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RLIVFPDLGV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
GLQDCTMLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLQDCTMLV	IFNg release	Negative		5	0	0	Blood	PBMC	HLA-A2	15272196	Yukari Takao; Akira Yamada; Shigeru Yutani; Michio Sata; Kyogo Itoh
LIYDSSLCDL	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	LIYDSSLCDL	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
FLPSDFFPSV	Occurrence of infectious disease						IL-2 release	Positive		11	4	36.4	Blood	PBMC	HLA-A2	15162529	Ruo-Bing Li; Hong-Song Chen; Yao Xie; Ran Fei; Xu Cong; Dong Jiang; Song-Xia Wang; Lai Wei; Yu Wang
FLPSDFFPSV	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	FLPSDFFPSV	IL-2 release	Positive		11			Blood	T cell CD8+	HLA-A2	15162529	Ruo-Bing Li; Hong-Song Chen; Yao Xie; Ran Fei; Xu Cong; Dong Jiang; Song-Xia Wang; Lai Wei; Yu Wang
FLPSDFFPSV	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	FLPSDFFPSV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A2	15162529	Ruo-Bing Li; Hong-Song Chen; Yao Xie; Ran Fei; Xu Cong; Dong Jiang; Song-Xia Wang; Lai Wei; Yu Wang
FVFLRNFSL	No immunization	Restimulation in vitro	PBMC	Dendritic cell	Epitope	FVFLRNFSL	qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FVFLRNFSL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FVFLRNFSL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FLFLRNFSL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FLFLRNFSL	qualitative binding	Positive	3.7				Blood	T cell CD8+	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FLFLRNFSL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FLFLRNFSL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FPPSPLFFFL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FPPSPLFFFL	qualitative binding	Positive	3.5				Blood	T cell CD8+	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FPPSPLFFFL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FPPSPLFFFL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FPPSPLFFFL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FPPSPLFFFL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
GASPAVSSL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		10	1	10	Blood	T cell CD8+	HLA class I	15153496	Christian Pelte; Georgy Cherepnev; Yanjun Wang; Constanze Schoenemann; Hans-Dieter Volk; Florian Kern
FPPSPLFFFL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FPPSPLFFFL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FLPSPLFFFL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FLPSPLFFFL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FLPSPLFFFL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FLPSPLFFFL	qualitative binding	Positive	20				Blood	T cell CD8+	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
FLPSPLFFFL	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	FLPSPLFFFL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15305339	Bj&ouml;rn Carlsson; Thomas H T&ouml;tterman; Magnus Essand
CMTWNQMNL	Occurrence of cancer						qualitative binding	Positive					Blood	T cell CD8+	HLA-A*24:02	15365188	Yoshihiro Oka; Akihiro Tsuboi; Tetsuya Taguchi; Tadashi Osaki; Taiichi Kyo; Hiroko Nakajima; Olga A Elisseeva; Yusuke Oji; Manabu Kawakami; Kazuhiro Ikegame; Naoki Hosen; Satoshi Yoshihara; Fei Wu; Fumihiro Fujiki; Masaki Murakami; Tomoki Masuda; Sumiyuki Nishida; Toshiaki Shirakata; Shin-Ichi Nakatsuka; Ayako Sasaki; Keiko Udaka; Hiroo Dohy; Katsuyuki Aozasa; Shinzaburo Noguchi; Ichiro Kawase; Haruo Sugiyama
CMTWNQMNL	Occurrence of cancer	Restimulation in vitro					IFNg release	Positive					Blood	T cell CD8+	HLA-A*24:02	15365188	Yoshihiro Oka; Akihiro Tsuboi; Tetsuya Taguchi; Tadashi Osaki; Taiichi Kyo; Hiroko Nakajima; Olga A Elisseeva; Yusuke Oji; Manabu Kawakami; Kazuhiro Ikegame; Naoki Hosen; Satoshi Yoshihara; Fei Wu; Fumihiro Fujiki; Masaki Murakami; Tomoki Masuda; Sumiyuki Nishida; Toshiaki Shirakata; Shin-Ichi Nakatsuka; Ayako Sasaki; Keiko Udaka; Hiroo Dohy; Katsuyuki Aozasa; Shinzaburo Noguchi; Ichiro Kawase; Haruo Sugiyama
CYTWNQMNL	Occurrence of cancer						qualitative binding	Positive					Blood	T cell CD8+	HLA-A*24:02	15365188	Yoshihiro Oka; Akihiro Tsuboi; Tetsuya Taguchi; Tadashi Osaki; Taiichi Kyo; Hiroko Nakajima; Olga A Elisseeva; Yusuke Oji; Manabu Kawakami; Kazuhiro Ikegame; Naoki Hosen; Satoshi Yoshihara; Fei Wu; Fumihiro Fujiki; Masaki Murakami; Tomoki Masuda; Sumiyuki Nishida; Toshiaki Shirakata; Shin-Ichi Nakatsuka; Ayako Sasaki; Keiko Udaka; Hiroo Dohy; Katsuyuki Aozasa; Shinzaburo Noguchi; Ichiro Kawase; Haruo Sugiyama
CYTWNQMNL	Administration in vivo	Restimulation in vitro					IFNg release	Positive		15	5	33.3	Blood	T cell CD8+	HLA-A*24:02	15365188	Yoshihiro Oka; Akihiro Tsuboi; Tetsuya Taguchi; Tadashi Osaki; Taiichi Kyo; Hiroko Nakajima; Olga A Elisseeva; Yusuke Oji; Manabu Kawakami; Kazuhiro Ikegame; Naoki Hosen; Satoshi Yoshihara; Fei Wu; Fumihiro Fujiki; Masaki Murakami; Tomoki Masuda; Sumiyuki Nishida; Toshiaki Shirakata; Shin-Ichi Nakatsuka; Ayako Sasaki; Keiko Udaka; Hiroo Dohy; Katsuyuki Aozasa; Shinzaburo Noguchi; Ichiro Kawase; Haruo Sugiyama
FIAGLIAIV	Occurrence of infectious disease						IFNg release	Positive		5	5	100	Blood	T cell CD8+	HLA-A2	15451471	Yue-Dan Wang; Wei Feng Chen
FIAGLIAIV	Occurrence of infectious disease						qualitative binding	Positive		5	5	100	Blood	T cell CD8+	HLA-A2	15451471	Yue-Dan Wang; Wei Feng Chen
FLWGPRALV	Occurrence of cancer	Restimulation in vitro					IFNg release	Positive		36	3	8.3	Blood	Lymphocyte	HLA-A2	15449035	Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson
GYDQIMPKK	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	GYDQIMPKK	cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA-A*24:02	15647119	Satoshi Kawaguchi; Takuro Wada; Kazunori Ida; Yuriko Sato; Satoshi Nagoya; Tomohide Tsukahara; Sigeharu Kimura; Hiroeki Sahara; Hideyuki Ikeda; Kumiko Shimozawa; Hiroko Asanuma; Toshihiko Torigoe; Hiroaki Hiraga; Takeshi Ishii; Shin-Ichiro Tatezaki; Noriyuki Sato; Toshihiko Yamashita
GYDQIMPKK	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	GYDQIMPKK	qualitative binding	Positive		5	5	100	Blood	PBMC	HLA-A*24:02	15647119	Satoshi Kawaguchi; Takuro Wada; Kazunori Ida; Yuriko Sato; Satoshi Nagoya; Tomohide Tsukahara; Sigeharu Kimura; Hiroeki Sahara; Hideyuki Ikeda; Kumiko Shimozawa; Hiroko Asanuma; Toshihiko Torigoe; Hiroaki Hiraga; Takeshi Ishii; Shin-Ichiro Tatezaki; Noriyuki Sato; Toshihiko Yamashita
ELAGIGILTV	Occurrence of cancer	Restimulation in vitro					IFNg release	Positive		36	3	8.3	Blood	Lymphocyte	HLA-A2	15449035	Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson
YMDGTMSQV	Occurrence of cancer	Restimulation in vitro					IFNg release	Positive		36	3	8.3	Blood	Lymphocyte	HLA-A2	15449035	Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson
YLEPGPVTVP	Occurrence of cancer	Restimulation in vitro					IFNg release	Positive		36	4	11.1	Blood	Lymphocyte	HLA-A2	15449035	Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson
IMDQVPFSV	Occurrence of cancer	Restimulation in vitro					IFNg release	Positive		36	4	11.1	Blood	Lymphocyte	HLA-A2	15449035	Peter Hersey; Scott W Menzies; Brendon Coventry; Tam Nguyen; Margaret Farrelly; Susan Collins; Debbie Hirst; Heather Johnson
QYDPVAALF	Exposure without evidence for disease	Restimulation in vitro	T cell	Dendritic cell	Epitope	QYDPVAALF	cytotoxicity	Positive		9	9	100	Blood	T cell CD8+	HLA-A24	15388261	Yasuto Akiyama; Kiyotaka Kuzushima; Tatsuya Tsurumi; Ken Yamaguchi
QYDPVAALF	Exposure without evidence for disease	Restimulation in vitro			Epitope	QYDPVAALF	qualitative binding	Positive		9	9	100	Blood	T cell CD8+	HLA-A24	15388261	Yasuto Akiyama; Kiyotaka Kuzushima; Tatsuya Tsurumi; Ken Yamaguchi
QYDPVAALF	Exposure without evidence for disease	Restimulation in vitro	T cell	Dendritic cell	Epitope	QYDPVAALF	IFNg release	Positive		9	9	100	Blood	T cell CD8+	HLA-A24	15388261	Yasuto Akiyama; Kiyotaka Kuzushima; Tatsuya Tsurumi; Ken Yamaguchi
DAEKSDICTDEY	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	DAEKSDICTDEY	IFNg release	Positive		14	13	92.9	Blood	PBMC	HLA-A1	15542798	Craig L Slingluff Jr; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jayashree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill
YLEPGPVTA	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	YLEPGPVTA	IFNg release	Positive		7	4	57.1	Blood	PBMC	HLA-A2	15542798	Craig L Slingluff Jr; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jayashree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill
YMDGTMSQV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	YMDGTMSQV	IFNg release	Positive		13	10	76.9	Blood	PBMC	HLA-A2	15542798	Craig L Slingluff Jr; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jayashree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill
ALLAVGATK	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	ALLAVGATK	IFNg release	Positive		6	3	50	Blood	PBMC	HLA-A3	15542798	Craig L Slingluff Jr; Gina R Petroni; Galina V Yamshchikov; Sarah Hibbitts; William W Grosh; Kimberly A Chianese-Bullock; Eric A Bissonette; Donna L Barnd; Donna H Deacon; James W Patterson; Jayashree Parekh; Patrice Y Neese; Elizabeth M H Woodson; Catherine J Wiernasz; Priscilla Merrill
YLSGANLNL	Occurrence of cancer						IFNg release	Positive		4	4	100	Blood	T cell	HLA-A*02:01	15102666	Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
YLSGANLNL	Occurrence of cancer						IFNg release	Positive		4	2	50	Blood	T cell	HLA-A*02:01	15102666	Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
QYSWFVNGTF	Occurrence of cancer						IFNg release	Positive		6	3	50	Blood	T cell	HLA-A*24:02	15102666	Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
QYSWFVNGTF	Occurrence of cancer						IFNg release	Positive		6	2	33.3	Blood	T cell	HLA-A*24:02	15102666	Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
TYACFVSNL	Occurrence of cancer						IFNg release	Positive		6	3	50	Blood	T cell	HLA-A*24:02	15102666	Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
TYACFVSNL	Occurrence of cancer						IFNg release	Positive		6	2	33.3	Blood	T cell	HLA-A*24:02	15102666	Ko-Jiunn Liu; Chuan-Cheng Wang; Li-Tzong Chen; Ann-Lii Cheng; Dong-Tsamn Lin; Yu-Chen Wu; Wei-Lan Yu; Yi-Mei Hung; Hui-Yu Yang; Shin-Hun Juang; Jacqueline Whang-Peng
YLEKESIYY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLEKESIYY	IFNg release	Positive		5	5	100	Blood	T cell CD8+	HLA-A1	15269378	Jojanneke Heidema; Godelieve J de Bree; Patricia M A De Graaff; Wendy W C van Maren; Peter Hoogerhout; Theo A Out; Jan L L Kimpen; Grada M van Bleek
YLEKESIYY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Taxonomic Child	Human respiratory syncytial virus A2	qualitative binding	Positive					Blood	T cell CD8+	HLA-A1	15269378	Jojanneke Heidema; Godelieve J de Bree; Patricia M A De Graaff; Wendy W C van Maren; Peter Hoogerhout; Theo A Out; Jan L L Kimpen; Grada M van Bleek
RLPADVLKK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Taxonomic Child	Human respiratory syncytial virus A2	IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA-A3	15269378	Jojanneke Heidema; Godelieve J de Bree; Patricia M A De Graaff; Wendy W C van Maren; Peter Hoogerhout; Theo A Out; Jan L L Kimpen; Grada M van Bleek
AELDRTEEY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Taxonomic Child	Human respiratory syncytial virus A2	IFNg release	Positive					Blood	T cell CD8+	HLA-B44	15269378	Jojanneke Heidema; Godelieve J de Bree; Patricia M A De Graaff; Wendy W C van Maren; Peter Hoogerhout; Theo A Out; Jan L L Kimpen; Grada M van Bleek
LHLYSHPIILGFRKI	Occurrence of infectious disease						IFNg release	Positive					Blood	T cell CD4+	HLA-A2	15494540	Eishiro Mizukoshi; John Sidney; Brian Livingston; Marc Ghany; Jay H Hoofnagle; Alessandro Sette; Barbara Rehermann
LHLYSHPIILGFRKI	Occurrence of infectious disease						IFNg release	Positive					Blood	T cell CD8+	HLA-A2	15494540	Eishiro Mizukoshi; John Sidney; Brian Livingston; Marc Ghany; Jay H Hoofnagle; Alessandro Sette; Barbara Rehermann
LHLYSHPIILGFRKI	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	PBMC	Epitope	LHLYSHPIILGFRKI	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A2	15494540	Eishiro Mizukoshi; John Sidney; Brian Livingston; Marc Ghany; Jay H Hoofnagle; Alessandro Sette; Barbara Rehermann
LMLGEFLKL	Occurrence of cancer	Restimulation in vitro	T cell CD8+	PBMC	Epitope	LMLGEFLKL	IFNg release	Positive		5	4	80	Blood	T cell CD8+	HLA-A*02:01	15603888	Kerstin Otto; Mads Hald Andersen; Andreas Eggert; Petra Keikavoussi; Lars &Oslash;stergaard Pedersen; J&ouml;rg C Rath; Markus B&ouml;ck; Eva-B Br&ouml;cker; Per Thor Straten; Eckhart K&auml;mpgen; J&uuml;rgen C Becker
KQAFTFSPTYKAFLC	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	PBMC	Epitope	KQAFTFSPTYKAFLC	cytotoxicity	Positive					Blood	T cell	HLA-A3	15494540	Eishiro Mizukoshi; John Sidney; Brian Livingston; Marc Ghany; Jay H Hoofnagle; Alessandro Sette; Barbara Rehermann
LLLLTVLTV	Occurrence of cancer	Primary induction in vitro	PBMC	PBMC	Epitope	LLLLTVLTV	qualitative binding	Positive					Blood	T cell CD8+	HLA-A2	15561890	Carmen Choi; Mathias Witzens; Marianna Bucur; Markus Feuerer; Nora Sommerfeldt; Andreas Trojan; Anthony Ho; Volker Schirrmacher; Hartmut Goldschmidt; Philipp Beckhove
LLLLTVLTV	Occurrence of cancer	Primary induction in vitro	T cell	Dendritic cell	Epitope	LLLLTVLTV	IFNg release	Positive					Blood	T cell	HLA-A2	15561890	Carmen Choi; Mathias Witzens; Marianna Bucur; Markus Feuerer; Nora Sommerfeldt; Andreas Trojan; Anthony Ho; Volker Schirrmacher; Hartmut Goldschmidt; Philipp Beckhove
LLLLTVLTV	Occurrence of cancer	Primary induction in vitro	T cell	Dendritic cell	Epitope	LLLLTVLTV	cytotoxicity	Positive			4		Blood	T cell	HLA-A2	15561890	Carmen Choi; Mathias Witzens; Marianna Bucur; Markus Feuerer; Nora Sommerfeldt; Andreas Trojan; Anthony Ho; Volker Schirrmacher; Hartmut Goldschmidt; Philipp Beckhove
LLLLTVLTV	Occurrence of cancer	Primary induction in vitro	T cell	Dendritic cell	Epitope	LLLLTVLTV	degranulation	Positive					Blood	T cell	HLA-A2	15561890	Carmen Choi; Mathias Witzens; Marianna Bucur; Markus Feuerer; Nora Sommerfeldt; Andreas Trojan; Anthony Ho; Volker Schirrmacher; Hartmut Goldschmidt; Philipp Beckhove
AAAAAIFVI	Occurrence of autoimmune disease	Restimulation in vitro	T cell	PBMC	Epitope	AAAAAIFVI	cytotoxicity	Positive		3	3	100	Blood	T cell CD8+	HLA-B*51:01	15529349	Hidekata Yasuoka; Yuka Okazaki; Yutaka Kawakami; Michito Hirakata; Hidetoshi Inoko; Yasuo Ikeda; Masataka Kuwana
YTDFVGEGL	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	IFNg release	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
YLLKPVQRI	No immunization						IFNg release	Positive	67				Blood	T cell CD8+	HLA-A*02:01	15683221	Neil H Segal; Nathalie E Blachere; Jose A Guevara-Pati&ntilde;o; Humilidad F Gallardo; Ho Yin A Shiu; Agnes Viale; Cristina R Antonescu; Jedd D Wolchok; Alan N Houghton
AMLDLLKSV	No immunization						IFNg release	Positive	166.7				Blood	T cell CD8+	HLA-A*02:01	15683221	Neil H Segal; Nathalie E Blachere; Jose A Guevara-Pati&ntilde;o; Humilidad F Gallardo; Ho Yin A Shiu; Agnes Viale; Cristina R Antonescu; Jedd D Wolchok; Alan N Houghton
MIMQGGFSV	No immunization						IFNg release	Positive	55.3				Blood	T cell CD8+	HLA-A*02:01	15683221	Neil H Segal; Nathalie E Blachere; Jose A Guevara-Pati&ntilde;o; Humilidad F Gallardo; Ho Yin A Shiu; Agnes Viale; Cristina R Antonescu; Jedd D Wolchok; Alan N Houghton
SLLMWITQV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	SLLMWITQV	IFNg release	Positive		19			Blood	T cell	HLA-A*02:01	15534491	Hung T Khong; James C Yang; Suzanne L Topalian; Richard M Sherry; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
AAGIGILTV	Occurrence of cancer	Restimulation in vitro	T cell	PBMC	Epitope	AAGIGILTV	qualitative binding	Positive		7	4	57.1	Blood	T cell CD8+	HLA-A2	15336780	Nitya G Chakraborty; Subhasis Chattopadhyay; Shikhar Mehrotra; Arvind Chhabra; Bijay Mukherji
EADPTGHSY	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	EADPTGHSY	cytotoxicity	Positive					Blood	T cell	HLA-A1	15336780	Nitya G Chakraborty; Subhasis Chattopadhyay; Shikhar Mehrotra; Arvind Chhabra; Bijay Mukherji
FLPSDFFPSV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLPSDFFPSV	IFNg release	Positive		2	2	100	Blood	T cell	HLA-A*02:01	15480991	Simon A Whalley; David Brown; George J M Webster; Ruth Jacobs; Stephanie Reignat; Antonio Bertoletti; Chong-Gee Teo; Vincent Emery; Geoffrey M Dusheiko
FLPPDFFPSV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLPPDFFPSV	IFNg release	Positive		2	2	100	Blood	T cell	HLA-A*02:01	15480991	Simon A Whalley; David Brown; George J M Webster; Ruth Jacobs; Stephanie Reignat; Antonio Bertoletti; Chong-Gee Teo; Vincent Emery; Geoffrey M Dusheiko
FLPSDFLPSV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLPSDFLPSV	IFNg release	Positive		2	2	100	Blood	T cell	HLA-A*02:01	15480991	Simon A Whalley; David Brown; George J M Webster; Ruth Jacobs; Stephanie Reignat; Antonio Bertoletti; Chong-Gee Teo; Vincent Emery; Geoffrey M Dusheiko
FLPSDFFPGV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLPSDFFPGV	IFNg release	Positive		2	1	50	Blood	T cell	HLA-A*02:01	15480991	Simon A Whalley; David Brown; George J M Webster; Ruth Jacobs; Stephanie Reignat; Antonio Bertoletti; Chong-Gee Teo; Vincent Emery; Geoffrey M Dusheiko
FLPADFFPSV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLPADFFPSV	IFNg release	Positive		2	1	50	Blood	T cell	HLA-A*02:01	15480991	Simon A Whalley; David Brown; George J M Webster; Ruth Jacobs; Stephanie Reignat; Antonio Bertoletti; Chong-Gee Teo; Vincent Emery; Geoffrey M Dusheiko
FLPSDTNMGL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLPSDTNMGL	IFNg release	Positive		2	1	50	Blood	T cell	HLA-A*02:01	15480991	Simon A Whalley; David Brown; George J M Webster; Ruth Jacobs; Stephanie Reignat; Antonio Bertoletti; Chong-Gee Teo; Vincent Emery; Geoffrey M Dusheiko
HSKKKCDEL	Occurrence of infectious disease						IFNg release	Positive		3	2	66.7	Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEL	Occurrence of infectious disease						qualitative binding	Positive		2	2	100	Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEL	Occurrence of infectious disease						cytotoxicity	Positive		1			Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	HSKKKCDEL	IFNg release	Positive		1			Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDELT	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	HSKKKCDELT	IFNg release	Positive					Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEF	Occurrence of infectious disease						IFNg release	Positive					Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEF	Occurrence of infectious disease						cytotoxicity	Positive		1			Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEF	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	HSKKKCDEF	IFNg release	Positive		1			Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEV	Occurrence of infectious disease						IFNg release	Positive					Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEV	Occurrence of infectious disease						cytotoxicity	Positive					Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKKKCDEV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	HSKKKCDEV	IFNg release	Positive		1			Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
VTEHDTLLY	Exposure without evidence for disease						qualitative binding	Positive					Blood	PBMC	HLA-A1	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
VLEETSVML	Exposure without evidence for disease						qualitative binding	Positive		26	14	53.8	Blood	PBMC	HLA-A2	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
CRVLCCYVL	Exposure without evidence for disease						qualitative binding	Positive		18	17	94.4	Blood	PBMC	HLA-B7	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
QIKVRVDMV	Exposure without evidence for disease						qualitative binding	Positive		13	7	53.8	Blood	PBMC	HLA-B8	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
ELKRKMIYM	Environmental exposure to endemic/ubiquitous agent without evidence for disease						qualitative binding	Positive		13	8	61.5	Blood	PBMC	HLA-B8	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
ELRRKMMYM	Exposure without evidence for disease						qualitative binding	Positive		13	8	61.5	Blood	PBMC	HLA-B8	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
YSEHPTFTSQY	Exposure without evidence for disease						qualitative binding	Positive		19	8	42.1	Blood	PBMC	HLA-A1	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
NLVPMVATV	Exposure without evidence for disease						qualitative binding	Positive		26	26	100	Blood	PBMC	HLA-A2	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
TPRVTGGGAM	Exposure without evidence for disease						qualitative binding	Positive		18	17	94.4	Blood	PBMC	HLA-B7	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
RPHERNGFTVL	Exposure without evidence for disease						qualitative binding	Positive		18	16	88.9	Blood	PBMC	HLA-B7	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
IPSINVHHY	Exposure without evidence for disease						qualitative binding	Positive		4	3	75	Blood	PBMC	HLA-B35	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
YVLDHLIVV	Exposure without evidence for disease						qualitative binding	Positive		40	23	57.5	Blood	PBMC	HLA-A2	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
RAKFKQLL	Exposure without evidence for disease						qualitative binding	Positive		40	23	57.5	Blood	PBMC	HLA-B8	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
GLCTLVAML	Exposure without evidence for disease						qualitative binding	Positive		40	36	90	Blood	PBMC	HLA-A2	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
EPLPQGQLTAY	Exposure without evidence for disease						qualitative binding	Positive		8	5	62.5	Blood	PBMC	HLA-B35	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
CLGGLLTMV	Exposure without evidence for disease						qualitative binding	Positive		40	21	52.5	Blood	PBMC	HLA-A2	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
FLRGRAYGL	Exposure without evidence for disease						qualitative binding	Positive		20	13	65	Blood	PBMC	HLA-B8	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
WAKWRLQTL	Exposure without evidence for disease						qualitative binding	Positive		20	9	45	Blood	PBMC	HLA-B8	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
HPVGEADYFEY	Exposure without evidence for disease						qualitative binding	Positive		8	5	62.5	Blood	PBMC	HLA-B35	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
YPLHEQHGM	Exposure without evidence for disease						qualitative binding	Positive		8	5	62.5	Blood	PBMC	HLA-B35	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
GILGFVFTL	Exposure without evidence for disease						qualitative binding	Positive		40	19	47.5	Blood	PBMC	HLA-A2	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
AIISGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	AIISGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
ELRSRYWAI	Exposure without evidence for disease						qualitative binding	Positive		20	5	25	Blood	PBMC	HLA-B8	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
AIISGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	AIISGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
VTEHDTLLY	Exposure without evidence for disease						qualitative binding	Positive		19	19	100	Blood	PBMC	HLA-A1	15585874	Naeem Khan; Andrew Hislop; Nancy Gudgeon; Mark Cobbold; Rajiv Khanna; Laxman Nayak; Alan B Rickinson; Paul A H Moss
YIGSGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIGSGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIGSGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIGSGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIIIGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIIIGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIIIGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIIIGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIILGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIILGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIILGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIILGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIISGISPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIISGISPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIISGISPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIISGISPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIISGDLPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIISGDLPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIISGDLPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIISGDLPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIISGDSWV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIISGDSWV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIISGDSWV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIISGDSWV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIISGDSPL	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIISGDSPL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YIISGDSPL	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YIISGDSPL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YLISGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YLISGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YLISGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YLISGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YLISGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YLISGDSPV	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YLISGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YLISGDSPV	cytotoxicity	Positive						Other	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YLISGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YLISGDSPV	proliferation	Negative						T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
YLISGDSPV	No immunization	Primary induction in vitro	T cell	T2 cells-Lymphoblast	Epitope	YLISGDSPV	cytotoxicity	Positive						T cell	HLA-A*02:01	15501984	Jooeun Bae; Jeffrey A Martinson; Hans G Klingemann
RAKFKQLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-B*08:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
LQHYREVAA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-C*08:02	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
YVLDHLIVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-A*02:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
RVRAYTYSK	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-A*03:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
AENAGNDAC	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-B*45:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
IACPIVMRYVLDHLI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-A*24:02	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
IACPIVMRYVLDHLI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-C*02:02	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
GLCTLVAML	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-A*02:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
YRSGIIAVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-B*39:06	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
FRNLAYGRTCVLGK	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-C*03:04	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
TLDYKPLSV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-A*02:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
RPQGGSRPEFVKL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-B*07:02	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
CYDHAQTHL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-A*24:02	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
ARYAYYLQF	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-B*27:05	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
FLDKGTYTL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-A*02:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
RRRKGWIPL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-B*27:05	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
TPRVTGGGAM	Occurrence of infectious disease						IFNg release	Positive		4	4	100	Blood	PBMC	HLA-B7	15556681	Brigitte Godard; Agn&egrave;s Gazagne; Alain Gey; Muriel Baptiste; Benoit Vingert; Beatrice Pegaz-Fiornet; Laurence Strompf; Wolf H Fridman; Denis Glotz; Eric Tartour
NLVPMVATV	Occurrence of infectious disease						IFNg release	Positive		14	10	71.4	Blood	T cell CD8+	HLA-A2	15556681	Brigitte Godard; Agn&egrave;s Gazagne; Alain Gey; Muriel Baptiste; Benoit Vingert; Beatrice Pegaz-Fiornet; Laurence Strompf; Wolf H Fridman; Denis Glotz; Eric Tartour
NLVPMVATV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	NLVPMVATV	qualitative binding	Positive		2	2	100	Blood	T cell CD8+	HLA-A2	15556681	Brigitte Godard; Agn&egrave;s Gazagne; Alain Gey; Muriel Baptiste; Benoit Vingert; Beatrice Pegaz-Fiornet; Laurence Strompf; Wolf H Fridman; Denis Glotz; Eric Tartour
FLPSDFFPSV	Occurrence of infectious disease						qualitative binding	Positive		21	15	71.4	Blood	T cell CD8+	HLA-A2	15081620	Yuzhang Wu; Jingbo Zhang; Shiyuan Chen; An Chen; Li Wang; Jingyi Li; Tingting Zhao; Liyun Zou; Yan Tang; L Tingrong; Fang Wang
FLLTRILTI	Occurrence of infectious disease						qualitative binding	Positive		21	16	76.2	Blood	T cell CD8+	HLA-A2	15081620	Yuzhang Wu; Jingbo Zhang; Shiyuan Chen; An Chen; Li Wang; Jingyi Li; Tingting Zhao; Liyun Zou; Yan Tang; L Tingrong; Fang Wang
WLSLLVPFV	Occurrence of infectious disease						qualitative binding	Positive		21	8	38.1	Blood	T cell CD8+	HLA-A2	15081620	Yuzhang Wu; Jingbo Zhang; Shiyuan Chen; An Chen; Li Wang; Jingyi Li; Tingting Zhao; Liyun Zou; Yan Tang; L Tingrong; Fang Wang
FLLSLGIHL	Occurrence of infectious disease						qualitative binding	Positive		21	15	71.4	Blood	T cell CD8+	HLA-A2	15081620	Yuzhang Wu; Jingbo Zhang; Shiyuan Chen; An Chen; Li Wang; Jingyi Li; Tingting Zhao; Liyun Zou; Yan Tang; L Tingrong; Fang Wang
NLVPMVATV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro					qualitative binding	Positive		13	13	100	Blood	T cell CD8+	HLA-A2	15050296	Qin Ouyang; Wolfgang M Wagner; Wei Zheng; Anders Wikby; Ed J Remarque; Graham Pawelec
NLVPMVATV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro					IFNg release	Positive		13	13	100	Blood	T cell CD8+	HLA-A2	15050296	Qin Ouyang; Wolfgang M Wagner; Wei Zheng; Anders Wikby; Ed J Remarque; Graham Pawelec
AAAAAIFVI	Occurrence of autoimmune disease	Restimulation in vitro	T cell	PBMC	Epitope	AAAAAIFVI	IFNg release	Positive		14	4	28.6	Blood	T cell CD8+	HLA-B*51:01	15529349	Hidekata Yasuoka; Yuka Okazaki; Yutaka Kawakami; Michito Hirakata; Hidetoshi Inoko; Yasuo Ikeda; Masataka Kuwana
DMWEHAFYL	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	DMWEHAFYL	cytotoxicity	Positive		8	3	37.5	Blood	T cell CD8+	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
DMWEHAFYL	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	DMWEHAFYL	cytotoxicity	Positive		8	3	37.5	Blood	T cell CD8+	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
DMWEHAFYL	Occurrence of infectious disease	Restimulation in vitro	T cell	T2 cells-Lymphoblast	Epitope	DMWEHAFYL	IFNg release	Positive	5.6	8	3	37.5	Blood	T cell CD8+	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
DMWEHAFYL	Occurrence of infectious disease	Restimulation in vitro	T cell	T2 cells-Lymphoblast	Epitope	DMWEHAFYL	TNF release	Positive	2.4	8	3	37.5	Blood	T cell CD8+	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
DMWEHAFYLQ	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	DMWEHAFYLQ	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
VLMGGVPGVE	Occurrence of infectious disease	Restimulation in vitro	T cell	T2 cells-Lymphoblast	Epitope	VLMGGVPGVE	IFNg release	Positive	40				Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
VLMGGVPGVE	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	VLMGGVPGVE	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
VLMGGVPGVE	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	VLMGGVPGVE	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
VLMGGVPGVE	Occurrence of infectious disease	Restimulation in vitro	T cell	T2 cells-Lymphoblast	Epitope	VLMGGVPGVE	TNF release	Positive	9				Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
GLSTHEGALL	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	GLSTHEGALL	cytotoxicity	Negative		8	0	0	Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
LLSERVATDL	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	LLSERVATDL	cytotoxicity	Negative		8	0	0	Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
GLLHHAPSL	Occurrence of infectious disease	Restimulation in vitro	T cell	T2 cells-Lymphoblast	Epitope	GLLHHAPSL	IFNg release	Positive	6.9				Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
GLLHHAPSL	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	GLLHHAPSL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
GLLHHAPSL	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	GLLHHAPSL	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
GLLHHAPSL	Occurrence of infectious disease	Restimulation in vitro	T cell	T2 cells-Lymphoblast	Epitope	GLLHHAPSL	TNF release	Positive	10.4				Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
LLAFTNPTV	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	LLAFTNPTV	cytotoxicity	Negative		8	0	0	Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
QLSDVIDRL	Occurrence of infectious disease	Restimulation in vitro	T cell	B cell	Epitope	QLSDVIDRL	cytotoxicity	Negative		8	0	0	Blood	T cell	HLA-A*02:01	15039371	Yuzhi Dong; Sandra Demaria; Xuming Sun; Fabio R Santori; Bill M Jesdale; Anne S De Groot; William N Rom; Yuri Bushkin
HERNGFTVL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD3+	Dendritic cell			IFNg release	Positive		12	2	16.7	Blood	T cell CD3+	HLA-B*40:01	15514011	Deepa Trivedi; Roxanne Y Williams; Richard J O'Reilly; Guenther Koehne
YMLDLQPETT	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-A*02:01	15609329	Sarah J Youde; Corinna M McCarthy; Karen J Thomas; Kelly L Smith; Stephen Man
YMLDLQPETT	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC			IFNg release	Positive		1	1	100	Blood	T cell	HLA-A*02:01	15609329	Sarah J Youde; Corinna M McCarthy; Karen J Thomas; Kelly L Smith; Stephen Man
TIHDIILECV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	TIHDIILECV	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-A*02:01	15609329	Sarah J Youde; Corinna M McCarthy; Karen J Thomas; Kelly L Smith; Stephen Man
FFPSIRDLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FFPSIRDLL	cytotoxicity	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
FFPSIRDLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FFPSIRDLL	IFNg release	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
FFPSIRDLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FFPSIRDLL	qualitative binding	Positive		4	4	100	Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
EYLVSFGVW	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	EYLVSFGVW	cytotoxicity	Negative					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
EYLVSFGVW	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	EYLVSFGVW	IFNg release	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
EYLVSFGVW	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	EYLVSFGVW	qualitative binding	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
SWWTSLNFL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SWWTSLNFL	cytotoxicity	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
SWWTSLNFL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SWWTSLNFL	IFNg release	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
SWWTSLNFL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SWWTSLNFL	qualitative binding	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
SWLSLLVPF	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SWLSLLVPF	cytotoxicity	Negative					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
SWLSLLVPF	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SWLSLLVPF	IFNg release	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
SWLSLLVPF	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SWLSLLVPF	qualitative binding	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
KYTSFPWLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KYTSFPWLL	cytotoxicity	Negative					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
KYTSFPWLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KYTSFPWLL	IFNg release	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
KYTSFPWLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KYTSFPWLL	qualitative binding	Positive					Blood	PBMC	HLA-A24	15368520	Yasuteru Kondo; Shinichi Asabe; Koju Kobayashi; Masaaki Shiina; Hirofumi Niitsuma; Yoshiyuki Ueno; Tomoo Kobayashi; Tooru Shimosegawa
RLNEVAKNL	No immunization	Primary induction in vitro	Lymphocyte	Dendritic cell	Epitope	RLNEVAKNL	IFNg release	Positive		11	7	63.6	Spleen	T cell	HLA-A*02:01	15016646	Baomei Wang; Huabiao Chen; Xiaodong Jiang; Minghui Zhang; Tao Wan; Nan Li; Xiangyang Zhou; Yanfeng Wu; Feng Yang; Yizhi Yu; Xiaoning Wang; Ruifu Yang; Xuetao Cao
RLNEVAKNL	No immunization	Primary induction in vitro	Lymphocyte	Dendritic cell	Epitope	RLNEVAKNL	cytotoxicity	Positive		11	7	63.6	Spleen	T cell	HLA-A*02:01	15016646	Baomei Wang; Huabiao Chen; Xiaodong Jiang; Minghui Zhang; Tao Wan; Nan Li; Xiangyang Zhou; Yanfeng Wu; Feng Yang; Yizhi Yu; Xiaoning Wang; Ruifu Yang; Xuetao Cao
RLNEVAKNL	No immunization	Primary induction in vitro	Lymphocyte	Dendritic cell	Epitope	RLNEVAKNL	cytotoxicity	Positive					Spleen	T cell	HLA-A*02:01	15016646	Baomei Wang; Huabiao Chen; Xiaodong Jiang; Minghui Zhang; Tao Wan; Nan Li; Xiangyang Zhou; Yanfeng Wu; Feng Yang; Yizhi Yu; Xiaoning Wang; Ruifu Yang; Xuetao Cao
RLNEVAKNL	No immunization	Primary induction in vitro	Lymphocyte	Dendritic cell	Epitope	RLNEVAKNL	IFNg release	Positive					Spleen	T cell	HLA-A*02:01	15016646	Baomei Wang; Huabiao Chen; Xiaodong Jiang; Minghui Zhang; Tao Wan; Nan Li; Xiangyang Zhou; Yanfeng Wu; Feng Yang; Yizhi Yu; Xiaoning Wang; Ruifu Yang; Xuetao Cao
RLNEVAKNL	No immunization	Primary induction in vitro	Lymphocyte	Dendritic cell	Epitope	RLNEVAKNL	qualitative binding	Positive	0.5				Spleen	T cell CD8+	HLA-A*02:01	15016646	Baomei Wang; Huabiao Chen; Xiaodong Jiang; Minghui Zhang; Tao Wan; Nan Li; Xiangyang Zhou; Yanfeng Wu; Feng Yang; Yizhi Yu; Xiaoning Wang; Ruifu Yang; Xuetao Cao
LPFEKSTVM	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	LPFEKSTVM	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B*35:01	14764717	Adrianus C M Boon; Gerrie de Mutsert; Debbie van Baarle; Derek J Smith; Alan S Lapedes; Ron A M Fouchier; Kees Sintnicolaas; Albert D M E Osterhaus; Guus F Rimmelzwaan
LPFEKSTVM	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	qualitative binding	Positive					Blood	T cell CD8+	HLA-B*35:01	14764717	Adrianus C M Boon; Gerrie de Mutsert; Debbie van Baarle; Derek J Smith; Alan S Lapedes; Ron A M Fouchier; Kees Sintnicolaas; Albert D M E Osterhaus; Guus F Rimmelzwaan
RPREATIIY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPREATIIY	IFNg release	Positive		10	2	20	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPREATIIY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPREATIIY	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPRDEVRVM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPRDEVRVM	IFNg release	Positive		10	3	30	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPRDEVRVM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPRDEVRVM	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPREATIIY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPREATIIY	IFNg release	Positive					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPRDEVRVM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPRDEVRVM	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
KPRDDAAAL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	KPRDDAAAL	IFNg release	Positive		10	1	10	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
KPRDDAAAL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	KPRDDAAAL	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
KPRDDAAAL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	KPRDDAAAL	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKIDDHDY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKIDDHDY	IFNg release	Positive		10	1	10	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKIDDHDY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKIDDHDY	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKIDDHDY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKIDDHDY	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKPDTETY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKPDTETY	IFNg release	Positive		10	2	20	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKPDTETY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKPDTETY	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKPDTETY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKPDTETY	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKPDYSAM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKPDYSAM	IFNg release	Positive		10	3	30	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKPDYSAM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKPDYSAM	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKPDYSAM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKPDYSAM	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKVEGLEY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKVEGLEY	IFNg release	Positive		10	6	60	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKVEGLEY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKVEGLEY	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPKVEGLEY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPKVEGLEY	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPRLDSITY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPRLDSITY	IFNg release	Positive		10	6	60	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPRLDSITY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPRLDSITY	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPRLDSITY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPRLDSITY	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPRYEIFVY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPRYEIFVY	IFNg release	Positive		10	2	20	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPRYEIFVY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPRYEIFVY	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPRYEIFVY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPRYEIFVY	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPKLRQGSY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPKLRQGSY	IFNg release	Positive		10	2	20	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPKLRQGSY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPKLRQGSY	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPKLRQGSY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPKLRQGSY	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
KPGCDAPAY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	KPGCDAPAY	IFNg release	Positive		10	2	20	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
KPGCDAPAY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	KPGCDAPAY	IFNg release	Positive		2	2	100	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
KPGCDAPAY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	KPGCDAPAY	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPGCDAPAY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPGCDAPAY	IFNg release	Positive		10	1	10	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPGCDAPAY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPGCDAPAY	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
RPGCDAPAY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RPGCDAPAY	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
SPKETWLRL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	SPKETWLRL	IFNg release	Positive		10	1	10	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
SPKETWLRL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	SPKETWLRL	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
SPKETWLRL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	SPKETWLRL	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
INYADRRWCF	Occurrence of infectious disease						IFNg release	Positive		1			Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
INYADRRWCF	Occurrence of infectious disease						qualitative binding	Positive		1	1	100	Blood	PBMC	HLA-A24	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
ILGDTAWDFG	Occurrence of infectious disease						IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
ILGDTAWDFG	Occurrence of infectious disease						IFNg release	Positive		2	2	100	Blood	T cell CD8+	HLA-B7	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
IEPSWADVKKDLISY	Occurrence of infectious disease						IFNg release	Positive		48	3	6.3	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
ADVKKDLISYGGGWK	Occurrence of infectious disease						IFNg release	Positive		48	1	2.1	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
AVSLDFSPGTSGSPI	Occurrence of infectious disease						IFNg release	Positive		48	1	2.1	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
FSPGTSGSPIIDKKG	Occurrence of infectious disease						IFNg release	Positive		48	1	2.1	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
ILAPTRVVAAEMEEA	Occurrence of infectious disease						IFNg release	Positive		48	7	14.6	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
EMEEALRGLPIRYQT	Occurrence of infectious disease						IFNg release	Positive		48	3	6.3	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
EAHFTDPASIAARGY	Occurrence of infectious disease						IFNg release	Positive		48	3	6.3	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
LDNINTPEGIIPSMF	Occurrence of infectious disease						IFNg release	Positive		48	2	4.2	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
TPEGIIPSMFEPERE	Occurrence of infectious disease						IFNg release	Positive		48	2	4.2	Blood	T cell CD8+	HLA class I	15827181	Cameron P Simmons; Tao Dong; Nguyen Vinh Chau; Nguyen Thi Phuong Dung; Tran Nguyen Bich Chau; Le Thi Thu Thao; Nguyen Thi Dung; Tran Tinh Hien; Sarah Rowland-Jones; Jeremy Farrar
SLLMWITQV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	SLLMWITQV	IFNg release	Positive		44	29	65.9	Blood	T cell	HLA-A*02:01	15534491	Hung T Khong; James C Yang; Suzanne L Topalian; Richard M Sherry; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
NPKASLLSL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	NPKASLLSL	qualitative binding	Positive		6	4	66.7	Blood	T cell CD8+	HLA-B7	15269378	Jojanneke Heidema; Godelieve J de Bree; Patricia M A De Graaff; Wendy W C van Maren; Peter Hoogerhout; Theo A Out; Jan L L Kimpen; Grada M van Bleek
KLLMVLMLA	Occurrence of cancer						IFNg release	Positive		8			Blood	PBMC	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
KLLMVLMLA	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	KLLMVLMLA	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
KLLMVLMLA	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	KLLMVLMLA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
LMVLMLAAL	Occurrence of cancer						IFNg release	Positive		8			Blood	PBMC	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
LMVLMLAAL	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	LMVLMLAAL	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
LMVLMLAAL	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	LMVLMLAAL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
FLNQTDETL	Occurrence of cancer						IFNg release	Positive		8			Blood	PBMC	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
FLNQTDETL	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	FLNQTDETL	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
FLNQTDETL	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	FLNQTDETL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
TLSNVEVFM	Occurrence of cancer						IFNg release	Negative		8			Blood	PBMC	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
TLSNVEVFM	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	TLSNVEVFM	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
MQLIYDSSL	Occurrence of cancer						IFNg release	Negative		8			Blood	PBMC	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
MQLIYDSSL	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	MQLIYDSSL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
TINPQVSKT	Occurrence of cancer						IFNg release	Positive		8			Blood	PBMC	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
TINPQVSKT	No immunization	Primary induction in vitro	T cell CD8+	T2 cells-Lymphoblast	Epitope	TINPQVSKT	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A2	15538043	Andr&eacute; Jaramillo; Kishore Narayanan; Lacey G Campbell; Nicholas D Benshoff; Lonnie Lybarger; Ted H Hansen; Timothy P Fleming; Jill R Dietz; T Mohanakumar
ITKKVADLVGF	Administration in vivo						cytotoxicity	Positive					Blood	T cell	HLA-B*57:01	15104676	V Corbi&egrave;re; H Nicolay; V Russo; V Stroobant; V Brichard; T Boon; P van der Bruggen
RAKFKQLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive						T cell	HLA-B*08:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
LQHYREVAA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-C*08:02	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
YVLDHLIVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-A*02:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
RVRAYTYSK	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-A*03:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
AENAGNDAC	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-B*45:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
GLCTLVAML	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-A*02:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
YRSGIIAVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-B*39:06	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
FRNLAYGRTCVLGK	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-C*03:04	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
TLDYKPLSV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-A*02:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
RPQGGSRPEFVKL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-B*07:02	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
CYDHAQTHL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-A*24:02	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
ARYAYYLQF	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-B*27:05	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
FLDKGTYTL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-A*02:01	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
RRRKGWIPL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human herpesvirus 4 strain B95-8	IFNg release	Positive						T cell	HLA-B*27:05	15684323	Victoria A Pudney; Alison M Leese; Alan B Rickinson; Andrew D Hislop
GLIDIAPHQI	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	GLIDIAPHQI	cytotoxicity	Positive						T cell CD8+	HLA-A*02:01	12010981	David C Flyer; Venkatesh Ramakrishna; Cara Miller; Helen Myers; Melanie McDaniel; Karen Root; Caroline Flournoy; Victor H Engelhard; David H Canaday; Jarrod A Marto; Mark M Ross; Donald F Hunt; Jeffrey Shabanowitz; Forest M White
GLIDIAPHQI	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	GLIDIAPHQI	cytotoxicity	Positive						T cell CD8+	HLA-A*02:01	12010981	David C Flyer; Venkatesh Ramakrishna; Cara Miller; Helen Myers; Melanie McDaniel; Karen Root; Caroline Flournoy; Victor H Engelhard; David H Canaday; Jarrod A Marto; Mark M Ross; Donald F Hunt; Jeffrey Shabanowitz; Forest M White
GLIDIAPHQISS	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	GLIDIAPHQISS	cytotoxicity	Positive						T cell CD8+	HLA-A*02:01	12010981	David C Flyer; Venkatesh Ramakrishna; Cara Miller; Helen Myers; Melanie McDaniel; Karen Root; Caroline Flournoy; Victor H Engelhard; David H Canaday; Jarrod A Marto; Mark M Ross; Donald F Hunt; Jeffrey Shabanowitz; Forest M White
GLIDIAPHQISS	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	GLIDIAPHQISS	cytotoxicity	Positive						T cell CD8+	HLA-A*02:01	12010981	David C Flyer; Venkatesh Ramakrishna; Cara Miller; Helen Myers; Melanie McDaniel; Karen Root; Caroline Flournoy; Victor H Engelhard; David H Canaday; Jarrod A Marto; Mark M Ross; Donald F Hunt; Jeffrey Shabanowitz; Forest M White
GLIDIAPHQISSV	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	GLIDIAPHQISSV	cytotoxicity	Positive						T cell CD8+	HLA-A*02:01	12010981	David C Flyer; Venkatesh Ramakrishna; Cara Miller; Helen Myers; Melanie McDaniel; Karen Root; Caroline Flournoy; Victor H Engelhard; David H Canaday; Jarrod A Marto; Mark M Ross; Donald F Hunt; Jeffrey Shabanowitz; Forest M White
GLIDIAPHQISSV	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	GLIDIAPHQISSV	cytotoxicity	Positive						T cell CD8+	HLA-A*02:01	12010981	David C Flyer; Venkatesh Ramakrishna; Cara Miller; Helen Myers; Melanie McDaniel; Karen Root; Caroline Flournoy; Victor H Engelhard; David H Canaday; Jarrod A Marto; Mark M Ross; Donald F Hunt; Jeffrey Shabanowitz; Forest M White
FVDYNFTIV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	FVDYNFTIV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	12356679	Laurence Van Overtvelt; Muriel Andrieu; Val&eacute;rie Verhasselt; Francine Connan; Jeannine Choppin; Vincent Vercruysse; Michel Goldman; Anne Hosmalin; Bernard Vray
FVDYNFTIV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	FVDYNFTIV	IFNg release	Positive					Blood	T cell CD8+	HLA-A*02:01	12356679	Laurence Van Overtvelt; Muriel Andrieu; Val&eacute;rie Verhasselt; Francine Connan; Jeannine Choppin; Vincent Vercruysse; Michel Goldman; Anne Hosmalin; Bernard Vray
GYDQIMPKK	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	GYDQIMPKK	cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA-A*24:02	15647119	Satoshi Kawaguchi; Takuro Wada; Kazunori Ida; Yuriko Sato; Satoshi Nagoya; Tomohide Tsukahara; Sigeharu Kimura; Hiroeki Sahara; Hideyuki Ikeda; Kumiko Shimozawa; Hiroko Asanuma; Toshihiko Torigoe; Hiroaki Hiraga; Takeshi Ishii; Shin-Ichiro Tatezaki; Noriyuki Sato; Toshihiko Yamashita
MPVGGQSSF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	MPVGGQSSF	IFNg release	Positive		10	7	70	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
MPVGGQSSF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	MPVGGQSSF	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
MPVGGQSSF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	MPVGGQSSF	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
LPGTAVVPL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	LPGTAVVPL	IFNg release	Positive		10	6	60	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
LPGTAVVPL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	LPGTAVVPL	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
LPGTAVVPL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	LPGTAVVPL	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
VPWQPAFVF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	VPWQPAFVF	IFNg release	Positive		10	4	40	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
VPWQPAFVF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	VPWQPAFVF	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
VPWQPAFVF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	VPWQPAFVF	IFNg release	Positive					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
EPYLDPATM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	EPYLDPATM	IFNg release	Negative		10	0	0	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
EPYLDPATM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	EPYLDPATM	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
EPYLDPATM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	EPYLDPATM	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
WPTLIGLAM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	WPTLIGLAM	IFNg release	Positive		10	5	50	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
WPTLIGLAM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	WPTLIGLAM	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
WPTLIGLAM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	WPTLIGLAM	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPAEFLENF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPAEFLENF	IFNg release	Positive		10	3	30	Blood	T cell CD8+	HLA-B*35:01	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPAEFLENF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPAEFLENF	IFNg release	Negative		2	0	0	Blood	T cell CD8+	HLA-B53	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
IPAEFLENF	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	IPAEFLENF	IFNg release	Negative					Blood	T cell CD8+	HLA-B7	15762882	A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
CLTEYILWV	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	Vaccinia virus NYCBH - Dryvax	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-A*02:01	12668642	Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
CLTEYILWV	Administration in vivo						qualitative binding	Positive		3	3	100	Blood	T cell CD8+	HLA-A*02:01	12668642	Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
CLTEYILWV	Administration in vivo						IFNg release	Positive		3	3	100	Blood	T cell	HLA-A*02:01	12668642	Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
KVDDTFYYV	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	Vaccinia virus NYCBH - Dryvax	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-A*02:01	12668642	Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
KVDDTFYYV	Administration in vivo						qualitative binding	Positive		3	3	100	Blood	T cell CD8+	HLA-A*02:01	12668642	Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
KVDDTFYYV	Administration in vivo						IFNg release	Positive		3	3	100	Blood	T cell	HLA-A*02:01	12668642	Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
LAPTRVVAAEME	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 4	cytotoxicity	Positive						T cell	HLA-B7	12023403	Iva Zivna; Sharone Green; David W Vaughn; Siripen Kalayanarooj; Henry A F Stephens; Dasnayanee Chandanayingyong; Ananda Nisalak; Francis A Ennis; Alan L Rothman
LAPTRVVAAEME	Occurrence of infectious disease						IFNg release	Positive		10	9	90	Blood	PBMC	HLA-B7	12023403	Iva Zivna; Sharone Green; David W Vaughn; Siripen Kalayanarooj; Henry A F Stephens; Dasnayanee Chandanayingyong; Ananda Nisalak; Francis A Ennis; Alan L Rothman
LAPTRVVAAEME	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 4	cytotoxicity	Positive		6	6	100		T cell	HLA-B7	12023403	Iva Zivna; Sharone Green; David W Vaughn; Siripen Kalayanarooj; Henry A F Stephens; Dasnayanee Chandanayingyong; Ananda Nisalak; Francis A Ennis; Alan L Rothman
GESRKTFVE	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 3	cytotoxicity	Positive						T cell	HLA-B7	12023403	Iva Zivna; Sharone Green; David W Vaughn; Siripen Kalayanarooj; Henry A F Stephens; Dasnayanee Chandanayingyong; Ananda Nisalak; Francis A Ennis; Alan L Rothman
YTDFVGEGL	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	IFNg release	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
YTDFVGEGL	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	cytotoxicity	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
SACDVSVRV	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	IFNg release	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
SACDVSVRV	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	IFNg release	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
SACDVSVRV	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	cytotoxicity	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
SACDVSVRVV	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	IFNg release	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
SACDVSVRVV	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	IFNg release	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
SACDVSVRVV	Administration in vivo	Restimulation in vitro	PBMC	Dendritic cell	Source Antigen	Solute carrier family 45 member 3	cytotoxicity	Positive						T cell CD8+	HLA-C*05:01	15048720	Rachel S Friedman; A Gregory Spies; Michael Kalos
LPFEKSTVM	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive					Blood	PBMC	HLA-B*35:01	11836437	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
LPFEKSTVM	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B*35:01	11836437	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
VLTDGNPPEV	Occurrence of infectious disease						GM-CSF release	Positive		3	3	100	Blood	T cell CD8+	HLA-A2	12778479	Hanni H&ouml;hn; Cornelius Kortsik; Glenn Tully; Katja Nilges; Antje Necker; Kirsten Freitag; Claudia Neukirch; Peter Galle; Hans L&ouml;hr; Markus J Maeurer
VLTDGNPPEV	Occurrence of infectious disease						GM-CSF release	Positive		3	3	100	Blood	T cell CD8+	HLA-A2	12778479	Hanni H&ouml;hn; Cornelius Kortsik; Glenn Tully; Katja Nilges; Antje Necker; Kirsten Freitag; Claudia Neukirch; Peter Galle; Hans L&ouml;hr; Markus J Maeurer
VLSDGNPPQV	Occurrence of infectious disease						GM-CSF release	Positive		3	3	100	Blood	T cell CD8+	HLA-A2	12778479	Hanni H&ouml;hn; Cornelius Kortsik; Glenn Tully; Katja Nilges; Antje Necker; Kirsten Freitag; Claudia Neukirch; Peter Galle; Hans L&ouml;hr; Markus J Maeurer
VPTDPNPPEV	Occurrence of infectious disease						GM-CSF release	Positive		3	3	100	Blood	T cell CD8+	HLA-A2	12778479	Hanni H&ouml;hn; Cornelius Kortsik; Glenn Tully; Katja Nilges; Antje Necker; Kirsten Freitag; Claudia Neukirch; Peter Galle; Hans L&ouml;hr; Markus J Maeurer
VLTDPNPQEV	Occurrence of infectious disease						GM-CSF release	Positive		3	3	100	Blood	T cell CD8+	HLA-A2	12778479	Hanni H&ouml;hn; Cornelius Kortsik; Glenn Tully; Katja Nilges; Antje Necker; Kirsten Freitag; Claudia Neukirch; Peter Galle; Hans L&ouml;hr; Markus J Maeurer
LPFDKSTIM	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive					Blood	PBMC	HLA-B*35:01	11836437	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
LPFDKSTIM	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Victoria/3/1975(H3N2))	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B*35:01	11836437	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
LPFDKPTIM	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive					Blood	PBMC	HLA-B*35:01	11836437	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
LPFDKPTIM	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B*35:01	11836437	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
VLGRLDQKL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Negative		2	0	0	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
AVAGAAILV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		4	1	25	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
LLAVLTAAPL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		8	6	75	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
TLLYPLFNL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Negative		4	0	0	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
FLLPDAQSI	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Negative		3	0	0	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
LLAVLTAAPL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLAVLTAAPL	IFNg release	Positive		2	2	100	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
VLGRLDQKL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		7	2	28.6	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
ALEAFAIAVA	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALEAFAIAVA	IFNg release	Positive		2	2	100	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
ALEAFAIAVA	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		7	2	28.6	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
LVVADLSFI	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		4	1	25	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
WLLSVLAAV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Negative		3	0	0	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
LLSVLAAVGL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		4	1	25	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
GIVIDPNGVV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Negative		4	0	0	Blood	T cell	HLA-A*02:01	12972510	Homayoun Shams; Peter F Barnes; Stephen E Weis; Peter Klucar; Benjamin Wizel
LMLGEFLKL	Occurrence of cancer	Restimulation in vitro	T cell CD8+	PBMC	Epitope	LMLGEFLKL	qualitative binding	Positive		5	4	80	Blood	T cell CD8+	HLA-A*02:01	15603888	Kerstin Otto; Mads Hald Andersen; Andreas Eggert; Petra Keikavoussi; Lars &Oslash;stergaard Pedersen; J&ouml;rg C Rath; Markus B&ouml;ck; Eva-B Br&ouml;cker; Per Thor Straten; Eckhart K&auml;mpgen; J&uuml;rgen C Becker
GLCTLVAML	Environmental exposure to endemic/ubiquitous agent without evidence for disease						perforin release	Positive		1			Blood	T cell CD8+	HLA-A*02:01	12594271	Eugene V Ravkov; Christy M Myrick; John D Altman
FLRGRAYGL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive		2			Blood	T cell CD8+	HLA-A*02:01	12594271	Eugene V Ravkov; Christy M Myrick; John D Altman
RAKFKQLL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		1			Blood	T cell CD8+	HLA-A*02:01	12594271	Eugene V Ravkov; Christy M Myrick; John D Altman
RAKFKQLL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						perforin release	Positive		1			Blood	T cell CD8+	HLA-A*02:01	12594271	Eugene V Ravkov; Christy M Myrick; John D Altman
KLEDENPWL	Occurrence of infectious disease						qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	15448372	Yi-Hsiang Huang; Mi-Hua Tao; Cheng-po Hu; Wan-Jr Syu; Jaw-Ching Wu
KLEDENPWL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KLEDENPWL	IFNg release	Positive					Blood	PBMC	HLA-A*02:01	15448372	Yi-Hsiang Huang; Mi-Hua Tao; Cheng-po Hu; Wan-Jr Syu; Jaw-Ching Wu
YILDLQPETT	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-A*02:01	15609329	Sarah J Youde; Corinna M McCarthy; Karen J Thomas; Kelly L Smith; Stephen Man
YVLDLQPEAT	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-A*02:01	15609329	Sarah J Youde; Corinna M McCarthy; Karen J Thomas; Kelly L Smith; Stephen Man
YMLDLQPETT	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC			IFNg release	Positive		1	1	100	Blood	T cell	HLA-A*02:01	15609329	Sarah J Youde; Corinna M McCarthy; Karen J Thomas; Kelly L Smith; Stephen Man
GLLGCIITSL	Occurrence of infectious disease						IFNg release	Positive		22	1	4.5	Blood	PBMC	HLA-A*02:01	15368525	P Martin; P Parroche; L Chatel; C Barretto; A Beck; C Tr&eacute;po; C Bain; Y C Lone; G Inchausp&eacute;; Anne Fournillier
NAHEGQLVI	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Hantaan virus 76-118	cytotoxicity	Positive		3	2	66.7	Blood	PBMC	HLA-B51	10364276	H L Van Epps; C S Schmaljohn; F A Ennis
AIMDKNIML	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	10364497	M Terajima; J Jameson; J E Norman; J Cruz; F A Ennis
AIMEKNIIL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	10364497	M Terajima; J Jameson; J E Norman; J Cruz; F A Ennis
AIMDKKIIL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	10364497	M Terajima; J Jameson; J E Norman; J Cruz; F A Ennis
CTELKLSDY	Unknown	Restimulation in vitro					IFNg release	Positive		2	2	100		T cell	HLA-A1	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
CTELKLSDY	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		9	5	55.6	Blood	T cell CD8+	HLA-A1	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
VSDGGPNLY	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		16	6	37.5	Blood	T cell CD8+	HLA-A1	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
AIMDKNIIL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		9	7	77.8	Blood	T cell CD8+	HLA-A*02:01	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
ASCMGLIY	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		11	4	36.4	Blood	T cell CD8+	HLA-B*35:01	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
ILRGSVAHK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell CD8+	PBMC	Source Organism	Influenza A virus	proliferation	Positive		1	1	100	Blood	T cell CD8+	HLA-A3	12399202	C Gschoesser; G Almanzar; U Hainz; J Ortin; D Schonitzer; H Schild; M Saurwein-Teissl; B Grubeck-Loebenstein
ILRGSVAHK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell CD8+	PBMC	Source Organism	Influenza A virus	proliferation	Positive		1	1	100	Blood	T cell CD8+	HLA class I	12399202	C Gschoesser; G Almanzar; U Hainz; J Ortin; D Schonitzer; H Schild; M Saurwein-Teissl; B Grubeck-Loebenstein
RLPLVLPAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RLPLVLPAV	cytotoxicity	Positive		2	1	50	Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RLPLVLPAV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	RLPLVLPAV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
MTYAAPLFV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	MTYAAPLFV	cytotoxicity	Positive		2	1	50	Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
SLYFGGICV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLYFGGICV	cytotoxicity	Positive		3	2	66.7	Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
SLYFGGICV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	SLYFGGICV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
SLYFGGICV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	SLYFGGICV	IFNg release	Positive					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LMIGTAAAV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	LMIGTAAAV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AMKGLPIRY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus type 3 CH53489	cytotoxicity	Positive					Blood	T cell	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
AMKGLPIRY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus type 3 CH53489	cytotoxicity	Positive					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
ALRGLPIRY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 2 Thailand/NGS-C/1944	cytotoxicity	Positive					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
SVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 3	cytotoxicity	Positive					Blood	T cell	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
SVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 3	cytotoxicity	Positive					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
DVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	Dengue virus type 3 CH53489	cytotoxicity	Positive					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
DVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	Dengue virus type 3 CH53489	proliferation	Negative					Blood	T cell	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
SVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 3	proliferation	Positive					Blood	T cell	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
GLLGCIITSL	Occurrence of infectious disease						IL-10 release	Positive		22	2	9.1	Blood	PBMC	HLA-A*02:01	15368525	P Martin; P Parroche; L Chatel; C Barretto; A Beck; C Tr&eacute;po; C Bain; Y C Lone; G Inchausp&eacute;; Anne Fournillier
LLGCIITSL	Occurrence of infectious disease						IL-10 release	Positive		22	3	13.6	Blood	PBMC	HLA-A*02:01	15368525	P Martin; P Parroche; L Chatel; C Barretto; A Beck; C Tr&eacute;po; C Bain; Y C Lone; G Inchausp&eacute;; Anne Fournillier
ILRGSVAHK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell CD8+	PBMC	Source Organism	Influenza A virus	proliferation	Positive		1	1	100	Blood	T cell CD8+	HLA-A3	12399202	C Gschoesser; G Almanzar; U Hainz; J Ortin; D Schonitzer; H Schild; M Saurwein-Teissl; B Grubeck-Loebenstein
ILRGSVAHK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell CD8+	PBMC	Source Organism	Influenza A virus	proliferation	Negative		1	0	0	Blood	T cell CD8+	HLA class I	12399202	C Gschoesser; G Almanzar; U Hainz; J Ortin; D Schonitzer; H Schild; M Saurwein-Teissl; B Grubeck-Loebenstein
FIYAGSLSAL	Administration in vivo	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	FIYAGSLSAL	cytotoxicity	Positive						T cell CD8+	HLA-A2	11086086	A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
FIYAGSLSAL	Administration in vivo	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	FIYAGSLSAL	cytotoxicity	Positive						T cell CD8+	HLA-A2	11086086	A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
KLVANNTRL	Administration in vivo	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	KLVANNTRL	cytotoxicity	Positive						T cell CD8+	HLA-A2	11086086	A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
KLVANNTRL	Administration in vivo	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	KLVANNTRL	cytotoxicity	Positive						T cell CD8+	HLA-A2	11086086	A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
KLVANNTRL	Administration in vivo	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	KLVANNTRL	IFNg release	Positive						T cell CD8+	HLA-A*02:01	11086086	A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
KLVANNTRL	Administration in vivo	Restimulation in vitro	T cell CD8+	Dendritic cell	Taxonomic Sibling	Mycobacterium bovis BCG	qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	11086086	A Geluk; K E van Meijgaarden; K L Franken; J W Drijfhout; S D'Souza; A Necker; K Huygen; T H Ottenhoff
HSKRKCDEL	Occurrence of infectious disease						cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA class I	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
HSKRKCDEF	Occurrence of infectious disease						cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA-B8	15611288	Joerg Timm; Georg M Lauer; Daniel G Kavanagh; Isabelle Sheridan; Arthur Y Kim; Michaela Lucas; Thillagavathie Pillay; Kei Ouchi; Laura L Reyor; Julian Schulze zur Wiesch; Rajesh T Gandhi; Raymond T Chung; Nina Bhardwaj; Paul Klenerman; Bruce D Walker; Todd M Allen
AMKGLPIRY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	AMKGLPIRY	cytotoxicity	Positive					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
ALRGLPIRY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	ALRGLPIRY	cytotoxicity	Positive					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
SVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	Dengue virus 2 Thailand/NGS-C/1944	cytotoxicity	Negative					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
SVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 3	cytotoxicity	Positive					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
DVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 2 Thailand/NGS-C/1944	cytotoxicity	Negative					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
DVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	DVKKDLISY	cytotoxicity	Negative					Blood	PBMC	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
DVKKDLISY	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	Dengue virus type 3 CH53489	cytotoxicity	Positive					Blood	T cell	HLA-B62	10453018	J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
AEMKTDAATL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD8+	Dendritic cell	Source Organism	Mycobacterium tuberculosis H37Rv	IFNg release	Positive					Blood	T cell CD8+	HLA-B44	11123322	D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson
AEMKTDAATL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive	1400				Blood	T cell	HLA-B44	11123322	D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson
AEMKTDAATL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD8+	Dendritic cell	Source Organism	Mycobacterium tuberculosis H37Rv	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B44	11123322	D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson
RADEEQQQAL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD8+	Dendritic cell	Source Organism	Mycobacterium tuberculosis H37Rv	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B14	11123322	D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson
RADEEQQQAL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD8+	Dendritic cell	Source Organism	Mycobacterium tuberculosis H37Rv	IFNg release	Positive					Blood	T cell CD8+	HLA-B14	11123322	D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson
RADEEQQQAL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive	500				Blood	T cell CD8+	HLA-B14	11123322	D M Lewinsohn; L Zhu; V J Madison; D C Dillon; S P Fling; S G Reed; K H Grabstein; M R Alderson
VLTDGNPPEV	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	VLTDGNPPEV	IFNg release	Positive		6	2	33.3	Blood	T cell CD8+	HLA-A2	11722642	H H&ouml;hn; C Kortsik; K Nilges; A Necker; K Freitag; G Tully; C Neukirch; M J Maeurer
VLTDGNPPEV	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	VLTDGNPPEV	IL-4 release	Positive		6	3	50	Blood	T cell CD8+	HLA-A2	11722642	H H&ouml;hn; C Kortsik; K Nilges; A Necker; K Freitag; G Tully; C Neukirch; M J Maeurer
VLTDGNPPEV	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	VLTDGNPPEV	GM-CSF release	Positive		6	2	33.3	Blood	T cell CD8+	HLA-A2	11722642	H H&ouml;hn; C Kortsik; K Nilges; A Necker; K Freitag; G Tully; C Neukirch; M J Maeurer
VLTDGNPPEV	Occurrence of infectious disease						IFNg release	Positive		3	1	33.3	Blood	T cell CD8+	HLA-A2	11722642	H H&ouml;hn; C Kortsik; K Nilges; A Necker; K Freitag; G Tully; C Neukirch; M J Maeurer
VLTDGNPPEV	Occurrence of infectious disease						IL-4 release	Positive		3	3	100	Blood	T cell CD8+	HLA-A2	11722642	H H&ouml;hn; C Kortsik; K Nilges; A Necker; K Freitag; G Tully; C Neukirch; M J Maeurer
FMYSDFHFI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	FMYSDFHFI	cytotoxicity	Positive		6	2	33.3	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
NMLSTVLGV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	NMLSTVLGV	cytotoxicity	Positive		6	2	33.3	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
ALLKHRFEI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALLKHRFEI	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SLENFRAYV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLENFRAYV	cytotoxicity	Positive					Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
LMDALKLSI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	LMDALKLSI	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
MLLRSAIGQV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	MLLRSAIGQV	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SMIEAESSV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SMIEAESSV	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RLIDFLKDV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RLIDFLKDV	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
GMFNMLSTV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GMFNMLSTV	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
WMMAMKYPI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	WMMAMKYPI	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RMQFSSFTV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RMQFSSFTV	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
GLISLILQI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLISLILQI	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SLCPIRGWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLCPIRGWAI	cytotoxicity	Positive		6	1	16.7	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
ALKMTMASV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALKMTMASV	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GILGFVFTL	cytotoxicity	Positive		8	8	100	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
ILGFVFTLTV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ILGFVFTLTV	cytotoxicity	Positive		6	4	66.7	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
FMYSDFHFI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	FMYSDFHFI	cytotoxicity	Positive					Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SLENFRAYV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLENFRAYV	cytotoxicity	Positive		6	2	33.3	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
NMLSTVLGV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	NMLSTVLGV	cytotoxicity	Positive					Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
ILGFVFTLTV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ILGFVFTLTV	cytotoxicity	Positive					Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GILGFVFTL	cytotoxicity	Positive		8	8	100	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SLCPIRGWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLCPIRGWAI	cytotoxicity	Positive					Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
GIAPLQLGK	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	GIAPLQLGK	cytotoxicity	Positive		6	2	33.3	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
GIAPLQLGK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GIAPLQLGK	cytotoxicity	Positive					Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
VTAACSHAGK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	VTAACSHAGK	cytotoxicity	Positive		6	1	16.7	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
VTAACSHAGK	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	VTAACSHAGK	cytotoxicity	Positive					Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
GIHHPSNSK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GIHHPSNSK	cytotoxicity	Positive		6	1	16.7	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RMNYYWTLLK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RMNYYWTLLK	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RTLDFHDSNVK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RTLDFHDSNVK	cytotoxicity	Positive		6	1	16.7	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RTLDFHDSNVK	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Epitope	RTLDFHDSNVK	cytotoxicity	Positive					Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SVRNGTYDYPK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SVRNGTYDYPK	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SIIPSGPLK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SIIPSGPLK	cytotoxicity	Positive		6	4	66.7	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SIIPSGPLK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SIIPSGPLK	cytotoxicity	Positive					Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RMVLASTTAK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RMVLASTTAK	cytotoxicity	Positive		6	2	33.3	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RMVLASTTAK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RMVLASTTAK	cytotoxicity	Positive					Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
GTHPSSSAGLK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GTHPSSSAGLK	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
KSMREEYRK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	KSMREEYRK	cytotoxicity	Positive		6	1	16.7	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
TMVMELVRMIK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	TMVMELVRMIK	cytotoxicity	Positive		6	2	33.3	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RVLSFIKGTK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RVLSFIKGTK	cytotoxicity	Positive		6	2	33.3	Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
RVLSFIKGTK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RVLSFIKGTK	cytotoxicity	Positive					Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
KSMREEYRK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	KSMREEYRK	cytotoxicity	Positive					Blood	PBMC	HLA-A*11:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
SAAFEDLRVLSFIRG	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	Lymphocyte	Lymphocyte	Epitope	SAAFEDLRVLSFIRG	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B37	2333291	B M Carreno; R W Anderson; J E Coligan; W E Biddison
SAAFEDLRVLSFIRG	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	Lymphocyte	Lymphocyte	Epitope	SAAFEDLRVLSFIRG	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B37	2333291	B M Carreno; R W Anderson; J E Coligan; W E Biddison
ISNQEPLKL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Hantaan virus 76-118	cytotoxicity	Positive		3	2	66.7	Blood	PBMC	HLA-A1	10364276	H L Van Epps; C S Schmaljohn; F A Ennis
FIAGLIAIV	Occurrence of infectious disease						IFNg release	Positive		12	12	100	Blood	PBMC	HLA-A2	15140958	Yue-Dan Wang; Wan-Yee Fion Sin; Guo-Bing Xu; Huang-Hao Yang; Tin-yau Wong; Xue-Wen Pang; Xiao-Yan He; Hua-Gang Zhang; Joice Na Lee Ng; Chak-Sum Samuel Cheng; Jing Yu; Li Meng; Rui-Feng Yang; Sik-To Lai; Zhi-Hong Guo; Yong Xie; Wei-Feng Chen; Huang-Hua Yang
GLYYLTTEV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLYYLTTEV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
FLMPVEDVFI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLMPVEDVFI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AMALLRLPLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	AMALLRLPLV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
FVVALIPLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FVVALIPLV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLMTAVYLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLMTAVYLV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ALVLLMLPVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALVLLMLPVV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LALVLLMLPV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LALVLLMLPV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RMFAANLGV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RMFAANLGV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLFRFMRPL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLFRFMRPL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
YLYVHSPAL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLYVHSPAL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ILFTFLHLA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ILFTFLHLA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
YLDLALMSV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLDLALMSV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
YLLALRYLA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLLALRYLA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLLDVTPLSL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLLDVTPLSL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLGSFELTGI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLGSFELTGI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
YLSQIAVLL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLSQIAVLL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
VLLLDVTPL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	VLLLDVTPL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
SLLEIGEGVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLLEIGEGVV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ILSSLGLPV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ILSSLGLPV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLFLGVVFL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLFLGVVFL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLWQDPVPA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLWQDPVPA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLFLTTEAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLFLTTEAV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
YTYKWETFL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YTYKWETFL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AMPAYNWMTV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	AMPAYNWMTV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ALLSDWLPA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALLSDWLPA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
SLLEIGEGV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLLEIGEGV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RMPAVTDLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RMPAVTDLV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AMLQDMAIL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	AMLQDMAIL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
MLQDMAILT	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	MLQDMAILT	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLAAGVADPV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLAAGVADPV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLFLTTEAVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLFLTTEAVV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
KLAGGVAVI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KLAGGVAVI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LMIGTAAAVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LMIGTAAAVV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AIMDKKIIL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	10364497	M Terajima; J Jameson; J E Norman; J Cruz; F A Ennis
MALLRLPLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	MALLRLPLV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RLMIGTAAA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RLMIGTAAA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RMSRVTTFTV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RMSRVTTFTV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GIVSGILLSI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GIVSGILLSI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
SLYFGGICVI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLYFGGICVI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ALVLLMLPV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALVLLMLPV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ILLSIARVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ILLSIARVV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLFRFMRPLI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLFRFMRPLI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLVDFVKHI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLVDFVKHI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
VLLEDGGVEV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	VLLEDGGVEV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLGGLGLFFA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLGGLGLFFA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
VLIAFGRFPI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	VLIAFGRFPI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
FLTCDANLAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLTCDANLAV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLLETSWEAI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLLETSWEAI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
KLTADGVLTA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KLTADGVLTA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
MLASTLTDA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	MLASTLTDA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLATVFKLTA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLATVFKLTA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AIAWGAWGEV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	AIAWGAWGEV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
WLLIDTSNA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	WLLIDTSNA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLYLSQIAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLYLSQIAV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
SLAGFVRML	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLAGFVRML	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
FMSLAGFVRM	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FMSLAGFVRM	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AVHDTLFYCV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	AVHDTLFYCV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RIANGMGATV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RIANGMGATV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
MLATDLSLRV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	MLATDLSLRV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RLQPQVGWEV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RLQPQVGWEV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AMKADIQHV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	AMKADIQHV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLLNCLWSV	Occurrence of infectious disease						IFNg release	Positive-Low					Blood	PBMC	HLA-A2	15140958	Yue-Dan Wang; Wan-Yee Fion Sin; Guo-Bing Xu; Huang-Hao Yang; Tin-yau Wong; Xue-Wen Pang; Xiao-Yan He; Hua-Gang Zhang; Joice Na Lee Ng; Chak-Sum Samuel Cheng; Jing Yu; Li Meng; Rui-Feng Yang; Sik-To Lai; Zhi-Hong Guo; Yong Xie; Wei-Feng Chen; Huang-Hua Yang
FKDGIYFAA	Occurrence of infectious disease						IFNg release	Negative					Blood	PBMC	HLA-A2	15140958	Yue-Dan Wang; Wan-Yee Fion Sin; Guo-Bing Xu; Huang-Hao Yang; Tin-yau Wong; Xue-Wen Pang; Xiao-Yan He; Hua-Gang Zhang; Joice Na Lee Ng; Chak-Sum Samuel Cheng; Jing Yu; Li Meng; Rui-Feng Yang; Sik-To Lai; Zhi-Hong Guo; Yong Xie; Wei-Feng Chen; Huang-Hua Yang
LITGRLAAL	Occurrence of infectious disease						IFNg release	Positive-Low					Blood	PBMC	HLA-A2	15140958	Yue-Dan Wang; Wan-Yee Fion Sin; Guo-Bing Xu; Huang-Hao Yang; Tin-yau Wong; Xue-Wen Pang; Xiao-Yan He; Hua-Gang Zhang; Joice Na Lee Ng; Chak-Sum Samuel Cheng; Jing Yu; Li Meng; Rui-Feng Yang; Sik-To Lai; Zhi-Hong Guo; Yong Xie; Wei-Feng Chen; Huang-Hua Yang
ISVVLIFVV	Occurrence of infectious disease						IFNg release	Negative					Blood	PBMC	HLA-A2	15140958	Yue-Dan Wang; Wan-Yee Fion Sin; Guo-Bing Xu; Huang-Hao Yang; Tin-yau Wong; Xue-Wen Pang; Xiao-Yan He; Hua-Gang Zhang; Joice Na Lee Ng; Chak-Sum Samuel Cheng; Jing Yu; Li Meng; Rui-Feng Yang; Sik-To Lai; Zhi-Hong Guo; Yong Xie; Wei-Feng Chen; Huang-Hua Yang
TVLRFVPPL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	TVLRFVPPL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLAGTVLRFV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLAGTVLRFV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RLLDDTPEV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RLLDDTPEV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
FLLADERVRV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLLADERVRV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLCCSGVATA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLCCSGVATA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
KIFMLVTAVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	KIFMLVTAVV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
DMWEHAFYL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	DMWEHAFYL	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ALYLLDGLRA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALYLLDGLRA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RLVSGLVGA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	RLVSGLVGA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
AIYHPQQFV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	AIYHPQQFV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ATYDKGILTV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	ATYDKGILTV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLYRQWALA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLYRQWALA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
MLGNAPSVV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	MLGNAPSVV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
GLYGAQYDV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	GLYGAQYDV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
YLSEGDMAA	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLSEGDMAA	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
FLLPDAQSI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLLPDAQSI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LMLPGMNGI	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LMLPGMNGI	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
WMAETTLGRV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	WMAETTLGRV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
LLPLGYPFV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLPLGYPFV	cytotoxicity	Negative					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
TPEGIIPTL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 4 Dominica/814669/1981	cytotoxicity	Positive						T cell CD8+	HLA-B*35:01	7529799	P G Livingston; I Kurane; L C Dai; Y Okamoto; C J Lai; R Men; S Karaki; M Takiguchi; F A Ennis
TPEGIIPTL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 4 Dominica/814669/1981	cytotoxicity	Positive						T cell CD8+	HLA-B*35:01	7529799	P G Livingston; I Kurane; L C Dai; Y Okamoto; C J Lai; R Men; S Karaki; M Takiguchi; F A Ennis
TPEGIIPTL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Dengue virus 4 Dominica/814669/1981	cytotoxicity	Positive						T cell CD8+	HLA-B*35:01	7529799	P G Livingston; I Kurane; L C Dai; Y Okamoto; C J Lai; R Men; S Karaki; M Takiguchi; F A Ennis
TPEGIIPSM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	Dengue virus 4 Dominica/814669/1981	cytotoxicity	Positive						T cell CD8+	HLA-B*35:01	7529799	P G Livingston; I Kurane; L C Dai; Y Okamoto; C J Lai; R Men; S Karaki; M Takiguchi; F A Ennis
RLPLVLPAV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	RLPLVLPAV	IFNg release	Positive					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
TPEGIIPTL	Administration in vivo						proliferation	Positive					Blood	PBMC	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
NPAQEDDQY	Administration in vivo						proliferation	Negative					Blood	PBMC	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
DPLKNDEDH	Administration in vivo						proliferation	Negative					Blood	PBMC	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
IPTLFGPER	Administration in vivo						proliferation	Negative					Blood	PBMC	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
GPEREKTQA	Administration in vivo						proliferation	Negative					Blood	PBMC	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
LPVWLSYKV	Administration in vivo						proliferation	Negative					Blood	PBMC	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
RPRWLDARV	Administration in vivo						proliferation	Negative					Blood	PBMC	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
DPMALKDFK	Administration in vivo						proliferation	Negative					Blood	PBMC	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
AIMDKNIIL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	10364497	M Terajima; J Jameson; J E Norman; J Cruz; F A Ennis
AIMDKNIIL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	10364497	M Terajima; J Jameson; J E Norman; J Cruz; F A Ennis
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell CD8+	T cell CD8-	Epitope	GILGFVFTL	IFNg release	Positive		29	28	96.6	Blood	T cell CD8+	HLA-A*02:01	12974795	H-G Zhang; X-W Pang; X-Y Shang; Q Xing; W-F Chen
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell CD8+	T cell CD8-	Epitope	GILGFVFTL	qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	12974795	H-G Zhang; X-W Pang; X-Y Shang; Q Xing; W-F Chen
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	GILGFVFTL	IFNg release	Positive		2	2	100	Blood	T cell CD8+	HLA-A*02:06	12974795	H-G Zhang; X-W Pang; X-Y Shang; Q Xing; W-F Chen
EPYLDPATM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Mycobacterium tuberculosis	IFNg release	Positive	22.5				Blood	T cell CD8+	HLA-B*35:01	11796635	Mich&egrave;l R Klein; Abdulrahman S Hammond; Steve M Smith; Assan Jaye; Pauline T Lukey; Keith P W J McAdam
LFAAFPSFA	Occurrence of infectious disease	Restimulation in vitro					TNF release	Positive		8	8	100		T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
LFAAFPSFA	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		3	3	100	Blood	T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
LFAAFPSFA	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
LFAAFPSFA	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
LFAAFPSFA	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	LFAAFPSFA	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
LFAAFPSFA	Occurrence of infectious disease						IFNg release	Positive						T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
GILTVSVAV	Occurrence of infectious disease	Restimulation in vitro					TNF release	Positive		8	8	100		T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
GILTVSVAV	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		3	3	100	Blood	T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
GILTVSVAV	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
GILTVSVAV	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
GILTVSVAV	No immunization	Primary induction in vitro	T cell CD8+	PBMC	Epitope	GILTVSVAV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
GILTVSVAV	Occurrence of infectious disease						IFNg release	Positive						T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
SLFPEFSEL	Occurrence of infectious disease	Restimulation in vitro					TNF release	Negative		8	0	0		T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
EMKEGRYEV	Occurrence of infectious disease	Restimulation in vitro					TNF release	Negative		8	0	0		T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
GADEDDIKA	Occurrence of infectious disease	Restimulation in vitro					TNF release	Negative		8	0	0		T cell CD8+	HLA-A*02:01	12232840	Nadia Caccamo; Salvatore Milano; Caterina Di Sano; Diego Cigna; Juraj Ivanyi; Alan M Krensky; Francesco Dieli; Alfredo Salerno
RLNEVAKNL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	qualitative binding	Positive		13	13	100	Blood	T cell CD8+	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
RLNEVAKNL	No immunization	Primary induction in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	qualitative binding	Positive		36	5	13.9	Blood	T cell CD8+	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
RLNEVAKNL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	IFNg release	Positive					Blood	PBMC	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
RLNEVAKNL	No immunization	Primary induction in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	IFNg release	Positive					Blood	PBMC	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
RLNEVAKNL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	cytotoxicity	Positive		13			Blood	T cell CD8+	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
RLNEVAKNL	No immunization	Primary induction in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	cytotoxicity	Positive		5			Blood	T cell CD8+	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
FIAGLIAIV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	IFNg release	Positive					Blood	PBMC	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
FIAGLIAIV	No immunization	Primary induction in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	IFNg release	Negative					Blood	PBMC	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
LITGRLQSL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	IFNg release	Positive					Blood	PBMC	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
LITGRLQSL	No immunization	Primary induction in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	IFNg release	Negative					Blood	PBMC	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
LLLNCLWSV	No immunization	Primary induction in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	IFNg release	Negative					Blood	PBMC	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
LITGRLAAL	No immunization	Primary induction in vitro	PBMC	PBMC	Source Organism	SARS coronavirus	IFNg release	Negative					Blood	PBMC	HLA-A*02:01	15972696	Huabiao Chen; Jinlin Hou; Xiaodong Jiang; Shiwu Ma; Minjie Meng; Baomei Wang; Minghui Zhang; Mingxia Zhang; Xiaoping Tang; Fuchun Zhang; Tao Wan; Nan Li; Yizhi Yu; Hongbo Hu; Ruifu Yang; Wei He; Xiaoning Wang; Xuetao Cao
RPHERNGFTVL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD3+	Dendritic cell			IFNg release	Positive		12	1	8.3	Blood	T cell CD3+	HLA-B*42:01	15514011	Deepa Trivedi; Roxanne Y Williams; Richard J O'Reilly; Guenther Koehne
RPHERNGFTV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD3+	Dendritic cell			IFNg release	Positive		12	1	8.3	Blood	T cell CD3+	HLA-B*07:02	15514011	Deepa Trivedi; Roxanne Y Williams; Richard J O'Reilly; Guenther Koehne
QYDPVAALF	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD3+	Dendritic cell			IFNg release	Positive		12	3	25	Blood	T cell CD3+	HLA-A*24:02	15514011	Deepa Trivedi; Roxanne Y Williams; Richard J O'Reilly; Guenther Koehne
NLVPMVATV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD3+	Dendritic cell			IFNg release	Positive		12	6	50	Blood	T cell CD3+	HLA-A*24:02	15514011	Deepa Trivedi; Roxanne Y Williams; Richard J O'Reilly; Guenther Koehne
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						perforin release	Positive		1			Blood	T cell CD8+	HLA-A*02:01	12594271	Eugene V Ravkov; Christy M Myrick; John D Altman
NLVPMVATV	Environmental exposure to endemic/ubiquitous agent without evidence for disease						perforin release	Positive		1			Blood	T cell CD8+	HLA-A*02:01	12594271	Eugene V Ravkov; Christy M Myrick; John D Altman
MLSTVLGVSI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	MLSTVLGVSI	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
LLTEVETPI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLTEVETPI	cytotoxicity	Negative		6	0	0	Blood	PBMC	HLA-A*02:01	10773346	C Gianfrani; C Oseroff; J Sidney; R W Chesnut; A Sette
ILRGSVAHK	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	Lymphoblast	Epitope	ILRGSVAHK	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A3	11531950	J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
SRYWAIRTR	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	Lymphoblast	Epitope	SRYWAIRTR	cytotoxicity	Positive					Blood	T cell	HLA-B27	11531950	J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
VLTDGNPPEV	Occurrence of infectious disease						qualitative binding	Positive		3	3	100	Blood	T cell CD8+	HLA-A2	11722642	H H&ouml;hn; C Kortsik; K Nilges; A Necker; K Freitag; G Tully; C Neukirch; M J Maeurer
SLYFGGICV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	SLYFGGICV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
RLPLVLPAV	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	RLPLVLPAV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11035787	S Cho; V Mehra; S Thoma-Uszynski; S Stenger; N Serbina; R J Mazzaccaro; J L Flynn; P F Barnes; S Southwood; E Celis; B R Bloom; R L Modlin; A Sette
ILRGSVAHK	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	Lymphoblast	Epitope	ILRGSVAHK	cytotoxicity	Positive					Blood	T cell	HLA-A3	11531950	J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
ILRGSVAHK	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	Lymphoblast	Epitope	ILRGSVAHK	cytotoxicity	Positive					Blood	T cell	HLA-A3	11531950	J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
SRYWAIRTR	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	Lymphoblast	Epitope	SRYWAIRTR	cytotoxicity	Positive					Blood	T cell	HLA-B27	11531950	J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
SRYWAIRTR	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	Lymphoblast	Epitope	SRYWAIRTR	cytotoxicity	Positive					Blood	T cell	HLA-B27	11531950	J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
GLFPTQIQV	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-A2	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
GLFPTQIQV	Occurrence of infectious disease						IFNg release	Positive		3	3	100	Blood	T cell CD8+	HLA-A2	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
RPKHLYVSM	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-B7	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
RPKHLYVSM	Occurrence of infectious disease						IFNg release	Positive		12	2	16.7	Blood	T cell CD8+	HLA-B7	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
RPKHLYVSM	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-B8	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
RPKHLYVSM	Occurrence of infectious disease						IFNg release	Positive		12	2	16.7	Blood	T cell CD8+	HLA-B8	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
ECPFIKPEV	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-B8	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
ECPFIKPEV	Occurrence of infectious disease						IFNg release	Positive		12	8	66.7	Blood	T cell CD8+	HLA-B8	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
IREFMEKECPFIKPE	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA class I	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
VRNIMSPVM	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA class I	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
TSFEDINGIRRPKHL	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-A28	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
TSFEDINGIRRPKHL	Occurrence of infectious disease						IFNg release	Negative		3	0	0	Blood	T cell CD8+	HLA-A28	12208874	Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
YLEKESIYY	Occurrence of infectious disease						qualitative binding	Positive					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
YLEKESIYY	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLEKESIYY	qualitative binding	Positive					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
YLEKESIYY	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLEKESIYY	proliferation	Positive					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
YLEKESIYY	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLEKESIYY	proliferation	Negative					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
YLEKESIYY	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	B cell	Epitope	YLEKESIYY	qualitative binding	Positive					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
YLEKESIYY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	YLEKESIYY	qualitative binding	Positive					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
NPKASLLSL	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	NPKASLLSL	qualitative binding	Positive					Blood	T cell CD8+	HLA-B7	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
NPKASLLSL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	NPKASLLSL	qualitative binding	Negative					Blood	T cell CD8+	HLA-B7	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
CTELKLSDY	Environmental exposure to endemic/ubiquitous agent without evidence for disease						qualitative binding	Positive					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
CTELKLSDY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	CTELKLSDY	qualitative binding	Positive					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
CTELKLSDY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	CTELKLSDY	qualitative binding	Positive					Blood	T cell CD8+	HLA-A1	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GILGFVFTL	qualitative binding	Positive					Blood	T cell CD8+	HLA-A2	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GILGFVFTL	qualitative binding	Positive					Blood	T cell CD8+	HLA-A2	15838799	Godelieve J de Bree; Jojanneke Heidema; Ester M M van Leeuwen; Grada M van Bleek; Ren&eacute; E Jonkers; Henk M Jansen; Ren&eacute; A W van Lier; Theo A Out
TVWFVPSIK	Occurrence of infectious disease						IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA class I	11709777	H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
NYADRRWCF	Occurrence of infectious disease						IFNg release	Positive		4	4	100	Blood	T cell CD8+	HLA class I	11709777	H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
YILRDVSKK	Occurrence of infectious disease						IFNg release	Positive		2	2	100	Blood	T cell CD8+	HLA class I	11709777	H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
DVFFTPPEK	Occurrence of infectious disease						IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA class I	11709777	H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
EALRGLPIR	Occurrence of infectious disease						IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA class I	11709777	H Loke; D B Bethell; C X Phuong; M Dung; J Schneider; N J White; N P Day; J Farrar; A V Hill
SLSAYIIRV	Administration in vivo	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	SLSAYIIRV	qualitative binding	Positive		1	1	100	Blood	PBMC	HLA-A*02:01	12518065	Ingo Drexler; Caroline Staib; Wolfgang Kastenmuller; Stefan Stevanovi; Burkhard Schmidt; Fran&ccedil;ois A Lemonnier; Hans-Georg Rammensee; Dirk H Busch; Helga Bernhard; Volker Erfle; Gerd Sutter
SLSAYIIRV	Administration in vivo	Restimulation in vitro	T cell CD8+	Dendritic cell	Epitope	SLSAYIIRV	cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA-A*02:01	12518065	Ingo Drexler; Caroline Staib; Wolfgang Kastenmuller; Stefan Stevanovi; Burkhard Schmidt; Fran&ccedil;ois A Lemonnier; Hans-Georg Rammensee; Dirk H Busch; Helga Bernhard; Volker Erfle; Gerd Sutter
YLLPRRGPRL	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	YLLPRRGPRL	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
ADLMGYIPLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	ADLMGYIPLV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
LLALLSCLTV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	LLALLSCLTV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
CINGVCWTV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	CINGVCWTV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
LLCPAGHAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	LLCPAGHAV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
TGAPVTYSTY	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	TGAPVTYSTY	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
KLVALGINAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	KLVALGINAV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
SLMAFTAAV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	SLMAFTAAV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
LLFNILGGWV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	LLFNILGGWV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
ILAGYGAGV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	ILAGYGAGV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
ILDSFDPLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	ILDSFDPLV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
RLIVFPDLGV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	RLIVFPDLGV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
MPVGGQSSF	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	MPVGGQSSF	IFNg release	Positive		2	1	50	Blood	T cell CD8+	HLA-B35	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
GLQDCTMLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	GLQDCTMLV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
ILHTPGCV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	ILHTPGCV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
QLRRIDLLV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	QLRRIDLLV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
SMVGNWAKV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	SMVGNWAKV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
SLLAPGAKQNV	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	SLLAPGAKQNV	IFNg release	Positive		10			Blood	T cell CD8+	HLA-A2	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
IPAEFLENF	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	IPAEFLENF	IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA-B35	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
WPTLIGLAM	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	WPTLIGLAM	IFNg release	Positive		2	2	100	Blood	T cell CD8+	HLA-B35	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
WPTLIGLAM	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	WPTLIGLAM	qualitative binding	Positive	3.48	1	1	100	Blood	T cell CD8+	HLA-B*35:01	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
WPTLIGLAM	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	WPTLIGLAM	IFNg release	Positive	21.8	1	1	100	Blood	T cell CD8+	HLA-B*35:01	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
WPTLIGLAM	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	WPTLIGLAM	cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-B*35:01	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
WPTLIGLAM	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	WPTLIGLAM	cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-B*35:01	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
MPVGGQSSF	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	MPVGGQSSF	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B35	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
IPAEFLENF	Administration in vivo	Restimulation in vitro	T cell CD8+	PBMC	Epitope	IPAEFLENF	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B35	11237810	M R Klein; S M Smith; A S Hammond; G S Ogg; A S King; J Vekemans; A Jaye; P T Lukey; K P McAdam
RVCEKMALY	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	RVCEKMALY	IFNg release	Positive		4			Blood	T cell CD8+	HLA-A3	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
MQLVDRVRGAVTGMSRRLVV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
HDGAGKRVY	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	HDGAGKRVY	IFNg release	Positive		4			Blood	T cell CD8+	HLA-A3	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
GPRLGFRAT	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	GPRLGFRAT	IFNg release	Positive		4			Blood	T cell CD8+	HLA-B7	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
VTGMSRRLVVGAVGAALVSG	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
DPRRRSRNL	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	DPRRRSRNL	IFNg release	Positive		4			Blood	T cell CD8+	HLA-B7	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
ASRCWVAM	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	ASRCWVAM	IFNg release	Positive		3			Blood	T cell CD8+	HLA-B35	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
NEGLGWAGW	Occurrence of infectious disease	Restimulation in vitro	PBMC	T cell CD8+	Epitope	NEGLGWAGW	IFNg release	Positive		2			Blood	T cell CD8+	HLA-B44	15558593	Norbert Hubert Gruener; Maria-Christina Jung; Axel Ulsenheimer; Joern Tilman Gerlach; Reinhart Zachoval; Helmut Michael Diepolder; Gustavo Baretton; Rolf Schauer; Gerd Rudolf Pape; Carl Albrecht Schirren
GLPVEYLQV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Positive		5	5	100	Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
GLPVEYLQV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	GLPVEYLQV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
GLPVEYLQV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	GLPVEYLQV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
GLPVEYLQV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	GLPVEYLQV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SRYWAIRTR	cytotoxicity	Positive					Lymphoid	T cell CD8+	HLA-B*27:05	15113903	E G M Berkhoff; A C M Boon; N J Nieuwkoop; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
GLPVEYLQV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	GLPVEYLQV	cytotoxicity	Positive		4	4	100	Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
GLPVEYLQV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	GLPVEYLQV	cytotoxicity	Positive		4	4	100	Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
GLPVEYLQV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	GLPVEYLQV	qualitative binding	Positive	5.97	3	3	100	Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
KLIANNTRV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Positive		5	5	100	Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
KLIANNTRV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	KLIANNTRV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
KLIANNTRV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	KLIANNTRV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
KLIANNTRV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	KLIANNTRV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
KLIANNTRV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	KLIANNTRV	cytotoxicity	Positive		4	4	100	Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
KLIANNTRV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	KLIANNTRV	cytotoxicity	Positive		4	4	100	Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
KLIANNTRV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Epitope	KLIANNTRV	qualitative binding	Positive	5.53	3	3	100	Blood	T cell CD8+	HLA-A*02:01	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Netherlands/785e/90 (H3N2))	IFNg release	Positive					Lymphoid	T cell CD8+	HLA-B*27:05	15113903	E G M Berkhoff; A C M Boon; N J Nieuwkoop; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
GAVGAALVSGLVGAVGGTAT	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
LVGAVGGTATAGAFSRPGLP	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
VEYLQVPSPSMGRDIKVQFQ	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
MGRDIKVQFQSGGANSPALY	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
SGGANSPALYLLDGLRAQDD	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
LLDGLRAQDDFSGWDINTPA	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
FSGWDINTPAFEWYDQSGLS	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
FEWYDQSGLSVVMPVGGQSS	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
VVMPVGGQSSFYSDWYQPAC	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
FYSDWYQPACGKAGCQTYKW	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Netherlands/785e/90 (H3N2))	IFNg release	Positive					Lymphoid	T cell CD8+	HLA-B*27:05	15113903	E G M Berkhoff; A C M Boon; N J Nieuwkoop; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
GKAGCQTYKWETFLTSELPG	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
ETFLTSELPGWLQANRHVKP	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
WLQANRHVKPTGSAVVGLSM	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
TGSAVVGLSMAASSALTLAI	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
AASSALTLAIYHPQQFVYAG	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
YHPQQFVYAGAMSGLLDPSQ	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
AMSGLLDPSQAMGPTLIGLA	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
AMGPTLIGLAMGDAGGYKAS	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
MGDAGGYKASDMWGPKEDPA	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
DMWGPKEDPAWQRNDPLLNV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
WQRNDPLLNVGKLIANNTRV	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
GKLIANNTRVWVYCGNGKPS	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
WVYCGNGKPSDLGGNNLPAK	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
DLGGNNLPAKFLEGFVRTSN	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
FLEGFVRTSNIKFQDAYNAG	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
IKFQDAYNAGGGHNGVFDFP	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
GGHNGVFDFPDSGTHSWEYW	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
DSGTHSWEYWGAQLNAMKPD	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
GAQLNAMKPDLQRALGATPN	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
LQRALGATPNTGPAPQGA	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
TGPAPQGA	Administration in vivo	Restimulation in vitro	T cell	PBMC	Taxonomic Sibling	Mycobacterium bovis BCG	IFNg release	Negative		5	0	0	Blood	T cell CD8+	HLA class I	11120838	S M Smith; R Brookes; M R Klein; A S Malin; P T Lukey; A S King; G S Ogg; A V Hill; H M Dockrell
SGYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Netherlands/018/94 (H3N2))	IFNg release	Negative					Lymphoid	T cell CD8+	HLA-B*27:05	15113903	E G M Berkhoff; A C M Boon; N J Nieuwkoop; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
GLPVEYLQV	Occurrence of infectious disease						IFNg release	Negative		2	0	0	Lung	T cell CD8+	HLA-A2	15699149	Glenn Tully; Cornelius Kortsik; Hanni H&ouml;hn; Ingeborg Zehbe; W E Hitzler; Claudia Neukirch; Kirsten Freitag; Klaus Kayser; Markus J Maeurer
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	11841689	A C M Boon; A P Vos; Y M F Graus; G F Rimmelzwaan; A D M E Osterhaus
KLIANNTRV	Occurrence of infectious disease						IFNg release	Positive		2	2	100	Lung	T cell CD8+	HLA-A2	15699149	Glenn Tully; Cornelius Kortsik; Hanni H&ouml;hn; Ingeborg Zehbe; W E Hitzler; Claudia Neukirch; Kirsten Freitag; Klaus Kayser; Markus J Maeurer
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	11841689	A C M Boon; A P Vos; Y M F Graus; G F Rimmelzwaan; A D M E Osterhaus
FIYAGSLSAL	Occurrence of infectious disease						IFNg release	Positive-Low		2	2	100	Lung	T cell CD8+	HLA-A2	15699149	Glenn Tully; Cornelius Kortsik; Hanni H&ouml;hn; Ingeborg Zehbe; W E Hitzler; Claudia Neukirch; Kirsten Freitag; Klaus Kayser; Markus J Maeurer
KLVANNTRL	Occurrence of infectious disease						IFNg release	Positive		2	2	100	Lung	T cell CD8+	HLA-A2	15699149	Glenn Tully; Cornelius Kortsik; Hanni H&ouml;hn; Ingeborg Zehbe; W E Hitzler; Claudia Neukirch; Kirsten Freitag; Klaus Kayser; Markus J Maeurer
VLTDGNPPEV	Occurrence of infectious disease						IFNg release	Positive		2	2	100	Lung	T cell CD8+	HLA-A2	15699149	Glenn Tully; Cornelius Kortsik; Hanni H&ouml;hn; Ingeborg Zehbe; W E Hitzler; Claudia Neukirch; Kirsten Freitag; Klaus Kayser; Markus J Maeurer
GILGFVFTL	Administration in vivo						qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	15004143	Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
GILGFVFTL	Administration in vivo	Restimulation in vitro					IFNg release	Positive					Blood	T cell CD8+	HLA-A*02:01	15004143	Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
GILGFVFTL	Administration in vivo						qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	15004143	Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
GILGFVFTL	Administration in vivo	Restimulation in vitro					IFNg release	Positive					Blood	T cell CD8+	HLA-A*02:01	15004143	Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
GILGFVFTL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Child	Influenza A virus (A/Sydney/5/1997(H3N2))	qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	15004143	Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
GILGFVFTL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Child	Influenza A virus (A/Sydney/5/1997(H3N2))	qualitative binding	Positive					Blood	T cell CD8+	HLA-A*02:01	15004143	Yuping Deng; Yu Jing; Ann E Campbell; Stefan Gravenstein
VLTDGNPPEV	Occurrence of infectious disease						qualitative binding	Positive		10	10	100	Blood	T cell CD8+	HLA-A2	12778479	Hanni H&ouml;hn; Cornelius Kortsik; Glenn Tully; Katja Nilges; Antje Necker; Kirsten Freitag; Claudia Neukirch; Peter Galle; Hans L&ouml;hr; Markus J Maeurer
AEMKTDAATL	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-B44	12969871	Deborah A Lewinsohn; Amy S Heinzel; James M Gardner; Liqing Zhu; Mark R Alderson; David M Lewinsohn
AEMKTDAATL	Occurrence of infectious disease	Restimulation in vitro					granzyme B release	Positive					Blood	T cell CD8+	HLA-B44	12969871	Deborah A Lewinsohn; Amy S Heinzel; James M Gardner; Liqing Zhu; Mark R Alderson; David M Lewinsohn
AEMKTDAATL	Occurrence of infectious disease	Restimulation in vitro					IFNg release	Positive					Blood	T cell CD8+	HLA-B44	12969871	Deborah A Lewinsohn; Amy S Heinzel; James M Gardner; Liqing Zhu; Mark R Alderson; David M Lewinsohn
TPEGIIPSL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	TPEGIIPTL	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
TPEGIIPAL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Taxonomic Sibling	TPEGIIPTL	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B35	7544398	J Zivny; I Kurane; A M Leporati; M Ibe; M Takiguchi; L L Zeng; M A Brinton; F A Ennis
VPTDPNPPEV	Occurrence of infectious disease						qualitative binding	Positive					Blood	T cell CD8+	HLA-A2	12778479	Hanni H&ouml;hn; Cornelius Kortsik; Glenn Tully; Katja Nilges; Antje Necker; Kirsten Freitag; Claudia Neukirch; Peter Galle; Hans L&ouml;hr; Markus J Maeurer
NVTSIHSLL	Occurrence of infectious disease	Restimulation in vitro					IFNg release	Positive					Blood	T cell CD8+	HLA-A*68:02	11009107	A A Pathan; K A Wilkinson; R J Wilkinson; M Latif; H McShane; G Pasvol; A V Hill; A Lalvani
NVTSIHSLL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD8+	PBMC	Epitope	NVTSIHSLL	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*68:02	11009107	A A Pathan; K A Wilkinson; R J Wilkinson; M Latif; H McShane; G Pasvol; A V Hill; A Lalvani
NVTSIHSLL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive					Blood	PBMC	HLA-A*68:02	11009107	A A Pathan; K A Wilkinson; R J Wilkinson; M Latif; H McShane; G Pasvol; A V Hill; A Lalvani
NVTSIHSLL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD8+	B cell	Epitope	NVTSIHSLL	IFNg release	Positive					Blood	T cell CD8+	HLA-A*68:02	11009107	A A Pathan; K A Wilkinson; R J Wilkinson; M Latif; H McShane; G Pasvol; A V Hill; A Lalvani
ILRGSVAHK	Environmental exposure to endemic/ubiquitous agent without evidence for disease						CXCL9/MIG release	Positive		2	2	100	Blood	T cell CD8+	HLA-A3	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						CXCL9/MIG release	Positive		6	6	100	Blood	T cell CD8+	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive		5	2	40	Blood	T cell CD8+	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
NLVPMVATV	Environmental exposure to endemic/ubiquitous agent without evidence for disease						CXCL9/MIG release	Positive		5	5	100	Blood	T cell CD8+	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
NLVPMVATV	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive		3	3	100	Blood	T cell CD8+	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
FLRGRAYGL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						CXCL9/MIG release	Positive		2	2	100	Blood	T cell CD8+	HLA-B8	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
FLRGRAYGL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA-B8	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
IKEYLNKIQNSLSTEWSPCSWSPCS	Administration in vivo						CXCL9/MIG release	Positive		2	2	100	Blood	PBMC	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
PSDKHIKEYLNKIQNSLSTE	Administration in vivo						CXCL9/MIG release	Positive		2	1	50	Blood	PBMC	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
ILSVSSFLFV	Administration in vivo						CXCL9/MIG release	Negative		2	0	0	Blood	PBMC	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
MMRKLAILSV	Administration in vivo						CXCL9/MIG release	Negative		2	0	0	Blood	PBMC	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
YLNKIQNSL	Administration in vivo						CXCL9/MIG release	Negative		2	0	0	Blood	PBMC	HLA-A*02:01	11687239	G T Brice; N L Graber; S L Hoffman; D L Doolan
KLAGGVAVI	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	KLAGGVAVI	IFNg release	Positive						T cell CD8+	HLA-A*02:01	11745380	J Charo; A Geluk; M Sundb&auml;ck; B Mirzai; A D Diehl; K J Malmberg; A Achour; S Huriguchi; K E van Meijgaarden; J W Drijfhout; N Beekman; P van Veelen; F Ossendorp; T H Ottenhoff; R Kiessling
HPFALLLVL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Yellow fever virus 17D	cytotoxicity	Positive						T cell CD8+	HLA-B*35:02	11853408	Mary Dawn T Co; Masanori Terajima; John Cruz; Francis A Ennis; Alan L Rothman
HPFALLLVL	Administration in vivo						IFNg release	Positive					Blood	PBMC	HLA-B*35:02	11853408	Mary Dawn T Co; Masanori Terajima; John Cruz; Francis A Ennis; Alan L Rothman
HAVPFGLVSM	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Yellow fever virus 17D	cytotoxicity	Positive						T cell CD8+	HLA-B*35:02	11853408	Mary Dawn T Co; Masanori Terajima; John Cruz; Francis A Ennis; Alan L Rothman
HAVPFGLVSM	Administration in vivo						IFNg release	Positive					Blood	PBMC	HLA-B*35:02	11853408	Mary Dawn T Co; Masanori Terajima; John Cruz; Francis A Ennis; Alan L Rothman
IPVIVADDL	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Yellow fever virus 17D	cytotoxicity	Positive						T cell CD8+	HLA-B*35:02	11853408	Mary Dawn T Co; Masanori Terajima; John Cruz; Francis A Ennis; Alan L Rothman
IPVIVADDL	Administration in vivo						IFNg release	Positive					Blood	PBMC	HLA-B*35:02	11853408	Mary Dawn T Co; Masanori Terajima; John Cruz; Francis A Ennis; Alan L Rothman
WNTGHDWILA	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Organism	Yellow fever virus 17D	cytotoxicity	Positive						T cell CD8+	HLA-B*35:02	11853408	Mary Dawn T Co; Masanori Terajima; John Cruz; Francis A Ennis; Alan L Rothman
WNTGHDWILA	Administration in vivo						IFNg release	Positive					Blood	PBMC	HLA-B*35:02	11853408	Mary Dawn T Co; Masanori Terajima; John Cruz; Francis A Ennis; Alan L Rothman
GLCTLVAML	Occurrence of infectious disease						qualitative binding	Positive		12	10	83.3	Synovial Fluid	T cell CD8+	HLA-A2	11062606	L C Tan; A G Mowat; C Fazou; T Rostron; H Roskell; P R Dunbar; C Tournay; F Romagn&eacute;; M A Peyrat; E Houssaint; M Bonneville; A B Rickinson; A J McMichael; M F Callan
RAKFKQLL	Occurrence of infectious disease						qualitative binding	Positive		5	5	100	Synovial Fluid	T cell CD8+	HLA-B8	11062606	L C Tan; A G Mowat; C Fazou; T Rostron; H Roskell; P R Dunbar; C Tournay; F Romagn&eacute;; M A Peyrat; E Houssaint; M Bonneville; A B Rickinson; A J McMichael; M F Callan
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	17	1	1	100	Blood	T cell	HLA-B27	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
GLCTLVAML	Occurrence of infectious disease						IFNg release	Positive		2	2	100	Synovial Fluid	T cell CD8+	HLA-A2	11062606	L C Tan; A G Mowat; C Fazou; T Rostron; H Roskell; P R Dunbar; C Tournay; F Romagn&eacute;; M A Peyrat; E Houssaint; M Bonneville; A B Rickinson; A J McMichael; M F Callan
RAKFKQLL	Occurrence of infectious disease						IFNg release	Positive		2	2	100	Synovial Fluid	Unknown/Unspecified	HLA-B8	11062606	L C Tan; A G Mowat; C Fazou; T Rostron; H Roskell; P R Dunbar; C Tournay; F Romagn&eacute;; M A Peyrat; E Houssaint; M Bonneville; A B Rickinson; A J McMichael; M F Callan
FLRGRAYGL	Occurrence of infectious disease						qualitative binding	Positive		5	2	40	Synovial Fluid	T cell CD8+	HLA-B8	11062606	L C Tan; A G Mowat; C Fazou; T Rostron; H Roskell; P R Dunbar; C Tournay; F Romagn&eacute;; M A Peyrat; E Houssaint; M Bonneville; A B Rickinson; A J McMichael; M F Callan
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	13.2	1	1	100	Blood	T cell	HLA-B27	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	26.5	1	1	100	Blood	T cell	HLA-B27	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	48.5	1	1	100	Blood	T cell	HLA-B27	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	31.4	1	1	100	Blood	T cell	HLA-A*02:01	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	42.5	1	1	100	Blood	T cell	HLA-A*02:01	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	64.9	1	1	100	Blood	T cell	HLA-A*02:01	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	45.6	1	1	100	Blood	T cell	HLA-A*02:01	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	43.5	1	1	100	Blood	T cell	HLA-A*02:01	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
AIMDKNIML	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	15.1	1	1	100	Blood	T cell	HLA-A*02:01	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
AIMDKNIML	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	18.7	1	1	100	Blood	T cell	HLA-A*02:01	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
AIMDKNIML	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	20	1	1	100	Blood	T cell	HLA-A*02:01	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
RRSGAAGAAVK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	13.7	1	1	100	Blood	T cell	HLA-B27	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
RRSGAAGAAVK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	10	1	1	100	Blood	T cell	HLA-B27	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
EDLTFLARS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	77.9	1	1	100	Blood	T cell	HLA class I	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
EDLTFLARS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	76.9	1	1	100	Blood	T cell	HLA class I	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
EDLTFLARS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	69.4	1	1	100	Blood	T cell	HLA class I	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
EDLTFLARS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	80.8	1	1	100	Blood	T cell	HLA class I	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
EDLTFLARS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	82.2	1	1	100	Blood	T cell	HLA class I	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
VETPIRNEW	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive	17	1	1	100	Blood	T cell	HLA-B44	10358215	J Jameson; J Cruz; M Terajima; F A Ennis
KTGGPIYKR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Positive						T cell	HLA-A68	9886403	E J Collins; B L Booth Jr; V Cerundolo
KTGGPAIYKR	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell	HLA-A68	9886403	E J Collins; B L Booth Jr; V Cerundolo
GLCTLVAML	Occurrence of infectious disease						qualitative binding	Positive		2	2	100	Synovial Fluid	T cell CD8+	HLA-A2	11062606	L C Tan; A G Mowat; C Fazou; T Rostron; H Roskell; P R Dunbar; C Tournay; F Romagn&eacute;; M A Peyrat; E Houssaint; M Bonneville; A B Rickinson; A J McMichael; M F Callan
RAKFKQLL	Occurrence of infectious disease						qualitative binding	Positive		2	2	100	Synovial Fluid	T cell CD8+	HLA-B8	11062606	L C Tan; A G Mowat; C Fazou; T Rostron; H Roskell; P R Dunbar; C Tournay; F Romagn&eacute;; M A Peyrat; E Houssaint; M Bonneville; A B Rickinson; A J McMichael; M F Callan
LQNLARTI	Occurrence of infectious disease						IFNg release	Positive		2	2	100	Blood	PBMC	HLA-B52	9419365	A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
LQNLARTI	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	B cell			IFNg release	Positive		2	2	100	Blood	T cell CD8+	HLA-B52	9419365	A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
LQNLARTI	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	B cell			IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA-B52	9419365	A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
LQNLARTI	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	B cell			cytotoxicity	Positive		2	2	100	Blood	T cell CD8+	HLA-B52	9419365	A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
LQNLARTI	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	B cell			cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-B52	9419365	A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
AMASTEGNV	Documented exposure without evidence for disease	Restimulation in vitro	T cell CD8+	B cell			IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA-B52	9419365	A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
AMASTEGNV	Occurrence of infectious disease						IFNg release	Positive		1	1	100	Blood	PBMC	HLA-A*02:01	9419365	A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
VSDGGPNLY	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	2	16.7	Blood	PBMC	HLA-A1	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
CTELKLSDY	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	2	16.7	Blood	PBMC	HLA-A1	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
GLCTLVAML	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	4	33.3	Blood	PBMC	HLA-A2	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
GILGFVFTL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	2	16.7	Blood	PBMC	HLA-A2	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
NLVPMVATV	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	2	16.7	Blood	PBMC	HLA-A2	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
ILRGSVAHK	Exposure with existing immune reactivity without evidence for disease						IFNg release	Negative		12	0	0	Blood	PBMC	HLA-A3	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
RVRAYTYSK	Exposure with existing immune reactivity without evidence for disease						IFNg release	Negative		12	0	0	Blood	PBMC	HLA-A3	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
RLRAEAQVK	Exposure with existing immune reactivity without evidence for disease						IFNg release	Negative		12	0	0	Blood	PBMC	HLA-A3	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
IVTDFSVIK	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	3	25	Blood	PBMC	HLA-A11	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
ATIGTAMYK	Exposure with existing immune reactivity without evidence for disease						IFNg release	Negative		12	0	0	Blood	PBMC	HLA-A11	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
DYCNVLNKEF	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	3	25	Blood	PBMC	HLA-A24	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
KTGGPIYKR	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	2	16.7	Blood	PBMC	HLA-A68	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
RKTPRVTGGGAMAGA	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	6	50	Blood	PBMC	HLA-B7	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
RPPIFIRRL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	2	16.7	Blood	PBMC	HLA-B7	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
QAKWRLQTL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	1	8.3	Blood	PBMC	HLA-B8	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
FLRGRAYGL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	2	16.7	Blood	PBMC	HLA-B8	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
RAKFKQLL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	3	25	Blood	PBMC	HLA-B8	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
ELRSRYWAI	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	3	25	Blood	PBMC	HLA-B8	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
RRIYDLIEL	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	1	8.3	Blood	PBMC	HLA-B27	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
SRYWAIRTR	Exposure with existing immune reactivity without evidence for disease						IFNg release	Negative		12	0	0	Blood	PBMC	HLA-B27	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
YPLHEQHGM	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	1	8.3	Blood	PBMC	HLA-B35	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
EENLLDFVRF	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	2	16.7	Blood	PBMC	HLA-B44	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
QEFFWDANDIYRIFA	Exposure with existing immune reactivity without evidence for disease						IFNg release	Positive		12	3	25	Blood	PBMC	HLA-B44	11792386	Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
RRSGAAGAAVK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B27	9765409	J Jameson; J Cruz; F A Ennis
RRSGAAGAAVK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B27	9765409	J Jameson; J Cruz; F A Ennis
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive					Blood	PBMC	HLA-B27	9765409	J Jameson; J Cruz; F A Ennis
VETPIRNEW	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B44	9765409	J Jameson; J Cruz; F A Ennis
VETPIRNEW	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Positive					Blood	T cell CD8+	HLA-B44	9765409	J Jameson; J Cruz; F A Ennis
AIMDKNIML	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive		1	0	0	Blood	PBMC	HLA-A*02:01	9765409	J Jameson; J Cruz; F A Ennis
RMPEAAPPV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	RMPEAAPPV	IFNg release	Positive		6	3	50	Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
LLGRNSFEV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	LLGRNSFEV	IFNg release	Positive		6	3	50	Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
GLAPPQHLIRV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	GLAPPQHLIRV	IFNg release	Positive		6	3	50	Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
SLPPPGTRV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	SLPPPGTRV	IFNg release	Positive		6	3	50	Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
KLCPVQLWV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	KLCPVQLWV	IFNg release	Positive		6	4	66.7	Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
YLGSYGFRL	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	YLGSYGFRL	IFNg release	Positive		6	3	50	Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
STPPPGATRV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	STPPPGATRV	IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
KTCPVQLWV	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	KTCPVQLWV	IFNg release	Positive		1	1	100	Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive					Blood	PBMC	HLA-A*02:01	9765409	J Jameson; J Cruz; F A Ennis
YQGSYGFRL	Occurrence of cancer	Restimulation in vitro	PBMC	PBMC	Epitope	YQGSYGFRL	IFNg release	Positive					Blood	T cell CD8+	HLA-A2	14985857	Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; S&oslash;ren Buus; Mogens H Claesson
RRSGAAGAAVK	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive		1	1	100	Blood	PBMC	HLA-B27	9765409	J Jameson; J Cruz; F A Ennis
RPIIRPATL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RPIIRPATL	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	9199964	P A Robbins; P A Rota; S Z Shapiro
ADRGLLRDI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ADRGLLRDI	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	9199964	P A Robbins; P A Rota; S Z Shapiro
ALKCKGFHV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ALKCKGFHV	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	9199964	P A Robbins; P A Rota; S Z Shapiro
SDKNKTNPI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SDKNKTNPI	cytotoxicity	Negative		1	1	100	Blood	T cell	HLA-B8	9199964	P A Robbins; P A Rota; S Z Shapiro
VRRMLSMNI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	VRRMLSMNI	cytotoxicity	Negative		1	1	100	Blood	T cell	HLA-B8	9199964	P A Robbins; P A Rota; S Z Shapiro
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive	285	9	7	77.8	Blood	T cell CD8+	HLA-A*02:01	9294140	A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive	67	7	5	71.4	Blood	T cell CD8+	HLA-B8	9294140	A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
ILRGSVAHK	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive	22	6	5	83.3	Blood	T cell CD8+	HLA-A3	9294140	A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
VSDGGPNLY	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive	11	4	2	50	Blood	T cell CD8+	HLA-A1	9294140	A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
ASCMGLIY	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive	62	2	2	100	Blood	T cell CD8+	HLA-B35	9294140	A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease						IFNg release	Positive	42	1	1	100	Blood	T cell CD8+	HLA-B*27:05	9294140	A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
RPIIRPATL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RPIIRPATL	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA class I	9199964	P A Robbins; P A Rota; S Z Shapiro
ADRGLLRDI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ADRGLLRDI	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA class I	9199964	P A Robbins; P A Rota; S Z Shapiro
RPIIRPATL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RPIIRPATL	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA class I	9199964	P A Robbins; P A Rota; S Z Shapiro
ILRGSVAHK	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		9	2	22.2	Blood	T cell CD8+	HLA-A3	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
ELRSRYWAI	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		16	7	43.8	Blood	T cell CD8+	HLA-B8	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
SRYWAIRTR	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		5	5	100	Blood	T cell CD8+	HLA-B*27:05	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
CTELKLSDY	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Negative		7	0	0	Blood	T cell CD8+	HLA-A1	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
RRSGAAGAAVK	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		5	3	60	Blood	T cell CD8+	HLA-B27	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
GILGFVFTL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus H3N2 (A/Resvir-9 (H3N2))	cytotoxicity	Positive		9	9	100	Blood	T cell CD8+	HLA-B*35:01	11752149	A C M Boon; G de Mutsert; Y M F Graus; R A M Fouchier; K Sintnicolaas; A D M E Osterhaus; G F Rimmelzwaan
SLLMWITQC	Occurrence of cancer	Restimulation in vitro	T cell	Unknown/Unspecified	Epitope	SLLMWITQC	IFNg release	Positive		2	2	100	Other	T cell CD8+	HLA-A*02:01	15004033	Andrew I Webb; Michelle A Dunstone; Weisan Chen; Marie-Isabel Aguilar; Qiyuan Chen; Heather Jackson; Linus Chang; Lars Kjer-Nielsen; Travis Beddoe; James McCluskey; Jamie Rossjohn; Anthony W Purcell
HERNGFTVL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	T cell CD3+	Dendritic cell			IFNg release	Positive		12	2	16.7	Blood	T cell CD3+	HLA-B*40:02	15514011	Deepa Trivedi; Roxanne Y Williams; Richard J O'Reilly; Guenther Koehne
RPIIRPATL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	RPIIRPATL	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA class I	9199964	P A Robbins; P A Rota; S Z Shapiro
ADRGLLRDI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ADRGLLRDI	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA class I	9199964	P A Robbins; P A Rota; S Z Shapiro
DVKKRRWVTF	No immunization	Primary induction in vitro	T cell CD8+	B cell	Source Antigen	Gag polyprotein	IFNg release	Negative					Lymphoid	T cell	HLA-B*44:03	15496958	E Kondo; Y Akatsuka; A Nawa; K Kuzushima; K Tsujimura; M Tanimoto; Y Kodera; Y Morishima; K Kuzuya; T Takahashi
DVKKRRWVTF	No immunization	Primary induction in vitro	T cell CD8+	B cell	Source Antigen	Gag polyprotein	IFNg release	Negative					Lymphoid	T cell	HLA-B*46:01	15496958	E Kondo; Y Akatsuka; A Nawa; K Kuzushima; K Tsujimura; M Tanimoto; Y Kodera; Y Morishima; K Kuzuya; T Takahashi
CSAEWPTF	No immunization	Primary induction in vitro	T cell CD8+	B cell	Source Antigen	gag protein	IFNg release	Positive					Lymphoid	T cell	HLA-B*46:01	15496958	E Kondo; Y Akatsuka; A Nawa; K Kuzushima; K Tsujimura; M Tanimoto; Y Kodera; Y Morishima; K Kuzuya; T Takahashi
LITQVKIKVF	No immunization	Primary induction in vitro	T cell CD8+	B cell	Source Antigen	Gag polyprotein	IFNg release	Negative					Lymphoid	T cell	HLA-B*46:01	15496958	E Kondo; Y Akatsuka; A Nawa; K Kuzushima; K Tsujimura; M Tanimoto; Y Kodera; Y Morishima; K Kuzuya; T Takahashi
GILGFVFTL	Unknown	Restimulation in vitro					cytotoxicity	Positive		1	1	100		T cell CD8+	HLA-A*02:01	9647214	C J Luckey; G M King; J A Marto; S Venketeswaran; B F Maier; V L Crotzer; T A Colella; J Shabanowitz; D F Hunt; V H Engelhard
EENLLDFVRF	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	B cell	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive		14	4	28.6	Blood	T cell	HLA-B44	1377222	R Khanna; S R Burrows; M G Kurilla; C A Jacob; I S Misko; T B Sculley; E Kieff; D J Moss
GNASRCWVAM	Occurrence of infectious disease						cytotoxicity	Positive					Liver	T cell CD8+	HLA-B35	1385523	M J Koziel; D Dudley; J T Wong; J Dienstag; M Houghton; R Ralston; B D Walker
LLFGYPVYV	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	LLFGYPVYV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A*02:01	1607654	U Utz; S Koenig; J E Coligan; W E Biddison
AWNAGFLRGRAYGIDLLRTE	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro					cytotoxicity	Positive						T cell CD8+	HLA-B8	1688611	S R Burrows; T B Sculley; I S Misko; C Schmidt; D J Moss
MVVKLGEFYNQMM	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	B cell	Epitope	MVVKLGEFYNQMM	cytotoxicity	Positive					Blood	T cell	HLA-A2	2480387	P A Robbins; L A Lettice; P Rota; J Santos-Aguado; J Rothbard; A J McMichael; J L Strominger
LRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/X-31(H3N2))	cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA-B*27:02	7542549	L G Tussey; S Rowland-Jones; T S Zheng; M J Androlewicz; P Cresswell; J A Frelinger; A J McMichael
STLPETTVVRR	Occurrence of infectious disease	Restimulation in vitro	T cell	PBMC	Epitope	STLPETTVVRR	cytotoxicity	Positive					Blood	T cell	HLA-A31	7679709	G Missale; A Redeker; J Person; P Fowler; S Guilhot; H J Schlicht; C Ferrari; F V Chisari
FLPSDFFPSV	Occurrence of infectious disease	Restimulation in vitro	T cell	PBMC	Epitope	FLPSDFFPSV	cytotoxicity	Positive					Blood	T cell	HLA-A2	7680391	A Bertoletti; F V Chisari; A Penna; S Guilhot; L Galati; G Missale; P Fowler; H J Schlicht; A Vitiello; R C Chesnut
IPSINVHHY	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	Fibroblast	Source Antigen	65 kDa lower matrix phosphoprotein	cytotoxicity	Positive					Blood	T cell	HLA-B*35:01	7691936	M A Gavin; M J Gilbert; S R Riddell; P D Greenberg; M J Bevan
IVTDFSVIK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell	HLA-A11	8384718	Q J Zhang; R Gavioli; G Klein; M G Masucci
TGAPVTYSTY	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell	HLA-A2	8523531	K Kurokohchi; T Akatsuka; C D Pendleton; A Takamizawa; M Nishioka; M Battegay; S M Feinstone; J A Berzofsky
GQIVGGVYL	Occurrence of infectious disease	Restimulation in vitro	T cell	Lymphocyte	Epitope	GQIVGGVYL	cytotoxicity	Positive		6	2	33.3	Blood	T cell CD8+	HLA-B60	8683220	T Kaneko; I Nakamura; H Kita; K Hiroishi; T Moriyama; M Imawari
ALQDSGLEV	Administration in vivo						cytotoxicity	Negative					Blood	PBMC	HLA-A*02:01	8697628	C Brander; G Corradin; T Hasler; W J Pichler
FLLTRILTI	Occurrence of infectious disease						cytotoxicity	Positive		17	10	58.8	Blood	PBMC	HLA-A*02:01	8837608	B Rehermann; C Ferrari; C Pasquinelli; F V Chisari
RAKFKQLL	Occurrence of infectious disease						cytotoxicity	Positive		3	3	100	Blood	PBMC	HLA-B8	9151898	N M Steven; N E Annels; A Kumar; A M Leese; M G Kurilla; A B Rickinson
VLTDGNPPEV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	VLTDGNPPEV	cytotoxicity	Positive		1	1	100	Blood	T cell CD8+	HLA-A*02:01	9725236	N Mohagheghpour; D Gammon; L M Kawamura; A van Vollenhoven; C J Benike; E G Engleman
SLDQSVVEL	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	Mononuclear cell	Epitope	SLDQSVVEL	cytotoxicity	Positive		9	1	11.1	Blood	T cell	HLA-A2	10352308	S K Kim; M Angevine; K Demick; L Ortiz; R Rudersdorf; D Watkins; R DeMars
NLVPIVATV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	11160752	J A Zaia; G Gallez-Hawkins; X Li; Z Q Yao; N Lomeli; K Molinder; C La Rosa; D J Diamond
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Epitope	GILGFVFTL	cytotoxicity	Positive					Blood	T cell	HLA-A2	1372560	J Morrison; J Elvin; F Latron; F Gotch; R Moots; J L Strominger; A McMichael
EENLLDFVRFMGVMSSCNNP	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro			Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive					Blood	T cell	HLA-B44	1695259	S R Burrows; I S Misko; T B Sculley; C Schmidt; D J Moss
RYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	Lymphocyte	Lymphocyte	Source Organism	Influenza A virus (A/X-31(H3N2))	cytotoxicity	Positive		2	2	100	Blood	T cell CD8+	HLA-B*27:05	2126195	S Huet; D F Nixon; J B Rothbard; A Townsend; S A Ellis; A J McMichael
PLGFFPDH	Administration in vivo	Restimulation in vitro	PBMC	PBMC	Source Antigen	Large envelope protein	proliferation	Positive					Blood	T cell CD8+	HLA-A11	2456369	Y Jin; W K Shih; I Berkower
KGILGFVFTLTV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	KGILGFVFTLTV	cytotoxicity	Positive					Blood	PBMC	HLA-A*02:01	3264322	F Gotch; A McMichael; J Rothbard
TTYQRTRAL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus (A/Japan/305/1957(H2N2))	cytotoxicity	Positive		4	2	50	Blood	PBMC	HLA-B14	7528217	M DiBrino; K C Parker; D H Margulies; J Shiloach; R V Turner; W E Biddison; J E Coligan
QPRAPIRPI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	B cell	Source Organism	Human herpesvirus 4 strain B95-8	cytotoxicity	Positive					Blood	T cell	HLA-B*07:02	7531143	A Hill; A Worth; T Elliott; S Rowland-Jones; J Brooks; A Rickinson; A McMichael
GGKKKYKLK	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	Unknown/Unspecified	Source Organism	Human immunodeficiency virus 1	cytotoxicity	Positive					Blood	PBMC	HLA-B8	7679646	J Sutton; S Rowland-Jones; W Rosenberg; D Nixon; F Gotch; X M Gao; N Murray; A Spoonas; P Driscoll; M Smith
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA-B8	7679646	J Sutton; S Rowland-Jones; W Rosenberg; D Nixon; F Gotch; X M Gao; N Murray; A Spoonas; P Driscoll; M Smith
VPYKRIEEL	Occurrence of infectious disease	Restimulation in vitro					cytotoxicity	Positive					Blood	T cell CD8+	HLA-B14	7690819	S Koenig; R M Woods; Y A Brewah; A J Newell; G M Jones; E Boone; J W Adelsberger; M W Baseler; S M Robinson; S Jacobson
ASCMGLIY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	B cell	Epitope	ASCMGLIY	cytotoxicity	Positive		6	6	100	Blood	T cell CD8+	HLA-B*35:01	8617300	T Dong; D Boyd; W Rosenberg; N Alp; M Takiguchi; A McMichael; S Rowland-Jones
NLVPMVATV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	NLVPMVATV	cytotoxicity	Positive		5	5	100	Blood	T cell	HLA-A2	9971792	M P Weekes; M R Wills; K Mynard; A J Carmichael; J G Sissons
RAKFKQLL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	B cell	Source Organism	Human gammaherpesvirus 4	cytotoxicity	Positive					Blood	T cell	HLA-B8	10051632	I S Misko; S M Cross; R Khanna; S L Elliott; C Schmidt; S J Pye; S L Silins
TYGPVFMSL	Occurrence of infectious disease						cytotoxicity	Negative		1	0	0	Other	T cell	HLA-A24	10411545	K Kuzushima; S Nakamura; T Nakamura; Y Yamamura; N Yokoyama; M Fujita; T Kiyono; T Tsurumi
LLPRRGPRL	Occurrence of infectious disease						cytotoxicity	Positive		5	2	40	Blood	T cell CD8+	HLA-A*02:01	10488697	H F L&ouml;hr; D Schmitz; M Arenz; S Weyer; G Gerken; K H Meyer zum B&uuml;schenfelde
RAKFKQLL	Occurrence of infectious disease						qualitative binding	Positive		3	3	100	Blood	T cell CD8+	HLA-B8	10915075	M T Roos; R A van Lier; D Hamann; G J Knol; I Verhoofstad; D van Baarle; F Miedema; P T Schellekens
STNPKPQK	Occurrence of infectious disease	Restimulation in vitro	PBMC	PBMC	Epitope	STNPKPQK	cytotoxicity	Positive		7	1	14.3	Blood	T cell CD8+	HLA-A11	11006009	M Cucchiarini; A R Kammer; B Grabscheid; H M Diepolder; T J Gerlach; N Gr&uuml;ner; T Santantonio; J Reichen; G R Pape; A Cerny
SLKKNSRSL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell CD8+	PBMC	Epitope	SLKKNSRSL	IFNg release	Positive		17	2	11.8	Blood	T cell CD8+	HLA-A*02:01	11012976	J M Gonz&aacute;lez; K Peter; F Esposito; I Nebi&eacute;; J M Tiercy; A Bonelo; M Ar&eacute;valo-Herrera; D Valmori; P Romero; S Herrera; G Corradin; J A L&oacute;pez
CLGGLLTMV	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	T2 cells-Lymphoblast	Epitope	CLGGLLTMV	cytotoxicity	Positive					Blood	T cell CD8+	HLA-A2	11035060	F Micheletti; A Canella; S Vertuani; M Marastoni; L Tosi; S Volinia; S Traniello; R Gavioli
ILKEPVHGV	No immunization						qualitative binding	Positive		31	23	74.2	Blood	T cell CD8+	HLA-A*02:01	11084618	T K Hoffmann; V S Donnenberg; U Friebe-Hoffmann; E M Meyer; C R Rinaldo; A B DeLeo; T L Whiteside; A D Donnenberg
QPTRVDQKM	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro			Epitope	QPTRVDQKM	cytotoxicity	Positive		2	2	100	Blood	T cell CD8+	HLA-B35	11119624	T Tolfvenstam; A Oxenius; D A Price; B L Shacklett; H M Spiegel; K Hedman; O Norbeck; M Levi; K Olsen; M Kantzanou; D F Nixon; K Broliden; P Klenerman
RLNMFTPYI	Occurrence of infectious disease	Restimulation in vitro	T cell CD8+	Mononuclear cell	Epitope	RLNMFTPYI	qualitative binding	Positive					Blood	T cell CD8+	HLA-A2	11120863	S K Kim; L Devine; M Angevine; R DeMars; P B Kavathas
RRLVVTLQC	Exposure with existing immune reactivity without evidence for disease						cytotoxicity	Positive					Synovial Fluid	T cell CD8+	HLA-B*27:05	11241274	X Saulquin; M Bodinier; M A Peyrat; A Hislop; E Scotet; F Lang; M Bonneville; E Houssaint
FLKEKKGL	Occurrence of infectious disease						qualitative binding	Positive		2	2	100	Blood	T cell CD8+	HLA-B8	11920575	Stefan Kostense; Sigrid A Otto; Gerlinde J Knol; Erik H Manting; Nening M Nanlohy; Christine Jansen; Joep M A Lange; Marinus H J van Oers; Frank Miedema; Debbie van Baarle
ILQDMRNTI	Exposure without evidence for disease	Restimulation in vitro	PBMC	T2 cells-Lymphoblast	Epitope	ILQDMRNTI	cytotoxicity	Positive		7	7	100	Blood	T cell	HLA-A*02:01	11961268	Ki-Young Lee; Eunyoung Chun; Na-Yeon Kim; Baik L Seong
KLMLDIHTV	No immunization	Primary induction in vitro	PBMC	Dendritic cell	Epitope	KLMLDIHTV	cytotoxicity	Positive		6	1	16.7	Blood	PBMC	HLA-A2	12100728	Fabiola Micheletti; Paolo Monini; Cinzia Fortini; Paola Rimessi; Martina Bazzaro; Massimo Andreoni; Massimo Giuliani; Serena Traniello; Barbara Ensoli; Riccardo Gavioli
FEDLRVLS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Fragment of Source Antigen	SAAFEDLRVLSFIRG	cytotoxicity	Positive					Blood	T cell	HLA-B37	1370522	B M Carreno; R V Turner; W E Biddison; J E Coligan
FEDLRVLS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	PBMC	Fragment of Source Antigen	SAAFEDLRVLSFIRG	cytotoxicity	Positive					Blood	T cell	HLA-B37	1370522	B M Carreno; R V Turner; W E Biddison; J E Coligan
TKGILGFVFTLTV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Positive		9	3	33.3	Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
SGPLKAEIAQRLEDV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Negative					Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
GKNTDLEVLMEWLKTRPILS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Positive					Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
RGLQRRRFVQNALNGNG	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Positive					Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
DPNNMDKAVKLYRKLKREI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Negative					Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
GLIYNRMGAVTTEVAFG	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Negative					Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
ASTTAKAMEQMAGS	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Negative					Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
SAGLKNDLLENLQAYQ	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Negative					Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
TKGILGFVFTLTV	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	T cell	B cell	Source Organism	Influenza A virus (A/Puerto Rico/8/1934(H1N1))	cytotoxicity	Positive					Blood	T cell	HLA-A2	2437457	F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Antigen	Nucleoprotein	cytotoxicity	Positive		6	5	83.3	Blood	PBMC	HLA-B8	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Antigen	Nucleoprotein	cytotoxicity	Positive		6	5	83.3	Blood	PBMC	HLA-B8	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
ILRGSVAHK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Antigen	Nucleoprotein	cytotoxicity	Positive		4	1	25	Blood	PBMC	HLA-A3	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
ILRGSVAHK	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Antigen	Nucleoprotein	cytotoxicity	Positive		4	2	50	Blood	PBMC	HLA-A3	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Antigen	Nucleoprotein	cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA-B*27:05	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Antigen	Nucleoprotein	cytotoxicity	Positive		1	1	100	Blood	PBMC	HLA-B*27:05	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Taxonomic Child	Influenza A virus (A/X-31(H3N2))	cytotoxicity	Positive		3	2	66.7	Blood	PBMC	HLA-B8	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
TPQDLNMML	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Antigen	gag protein	cytotoxicity	Positive					Blood	PBMC	HLA-B53	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
TPQDLNMML	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human immunodeficiency virus 1	cytotoxicity	Positive					Blood	PBMC	HLA-B53	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
YVDRFFKTL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Antigen	gag protein	cytotoxicity	Positive					Blood	PBMC	HLA-A26	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
YVDRFFKTL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Human immunodeficiency virus 1	cytotoxicity	Positive					Blood	PBMC	HLA-A26	10930688	L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard
AAFEDLRVLSFIRG	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive		4	4	100	Blood	T cell	HLA-B37	2430041	A J McMichael; F M Gotch; J Rothbard
AAFEDLRVLSFIRG	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Source Organism	Influenza A virus	cytotoxicity	Positive					Blood	T cell	HLA-B37	2430041	A J McMichael; F M Gotch; J Rothbard
KLGEFYNQM	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	Lymphocyte	B cell	Source Organism	Influenza B virus	cytotoxicity	Positive					Blood	T cell	HLA-A*02:01	7529284	P A Robbins; D N Garboczi; J L Strominger
GILGFVFTL	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	GILGFVFTL	cytotoxicity	Positive					Blood	PBMC	HLA-A*02:01	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
ASCMGLIY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ASCMGLIY	cytotoxicity	Positive					Blood	PBMC	HLA-B35	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ELRSRYWAI	cytotoxicity	Positive					Blood	PBMC	HLA-B8	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
SRYWAIRTR	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SRYWAIRTR	cytotoxicity	Positive					Blood	PBMC	HLA-B*27:05	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
YPLHEQHGM	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	YPLHEQHGM	cytotoxicity	Positive					Blood	PBMC	HLA-B35	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
SLYNTVATL	No immunization	Primary induction in vitro	PBMC	PBMC	Epitope	SLYNTVATL	cytotoxicity	Negative					Blood	PBMC	HLA-A*02:01	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
SLYNTVATL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLYNTVATL	cytotoxicity	Positive					Blood	PBMC	HLA-A*02:01	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
SLYNTVATL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	SLYNTVATL	qualitative binding	Positive					Blood	PBMC	HLA-A*02:01	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
ASCMGLIY	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ASCMGLIY	cytotoxicity	Positive					Blood	PBMC	HLA-B35	9502585	A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ELRSRYWAI	cytotoxicity	Positive		3	3	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ELRSRYWAI	cytotoxicity	Positive		3	3	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ELRSRYWAI	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
ELRSRYWAI	Environmental exposure to endemic/ubiquitous agent without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ELRSRYWAI	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
ELRSRYWAI	Unknown	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
PARSLREWEL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	PARSLREWEL	cytotoxicity	Negative		2	0	0	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
QRRYRRIYPL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	QRRYRRIYPL	cytotoxicity	Negative		2	0	0	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
ADRPRAWRL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	ADRPRAWRL	cytotoxicity	Negative		2	0	0	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
IVKQRRWKL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	IVKQRRWKL	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
IVKQRRWKL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	IVKQRRWKL	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
IVKQRRWKL	Unknown	Restimulation in vitro	PBMC	PBMC			cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
FLRGRAYGL	Exposure with existing immune reactivity without evidence for disease	Restimulation in vitro	PBMC	PBMC	Epitope	FLRGRAYGL	cytotoxicity	Positive		1	1	100	Blood	T cell	HLA-B8	7685314	A Suhrbier; C Schmidt; A Fernan
ILKEPVHGV	Unknown	Restimulation in vitro					qualitative binding	Positive						T cell CD8+	HLA-A2	8810254	J D Altman; P A Moss; P J Goulder; D H Barouch; M G McHeyzer-Williams; J I Bell; A J McMichael; M M Davis